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In this thesis a framework for estimating production losses and monetary costs 
of  generic  clinical  mastitis  (CM)  was  developed  and  possible  applications  were 
demonstrated.  Milk  Losses  were  estimated  from  5  large,  high  producing,  dairy 
herds that used automatic recording of daily milk yields by using mixed models, 
with a random herd effect and an autoregressive covariance structure to account for 
repeated  measurements.  Generalized  mixed  models,  with  a  random  herd  effect, 
were used to quantify the effect of CM on mortality and culling. Generalized mixed 
models, with a random herd effect, were used to estimate the conditional risks for 
the  first  3  CM  occurrences.  A  specially  structured  optimization  and  simulation 
model  based  on  multilevel  hierarchical  Markov  process  that  included  a  detailed 
representation of repeated episodes of CM was used to study the effects of various 
factors on the cost of CM. The average cost of CM in our study herds was $179.  In 
the basic scenario 92%  of the CM cases were recommended to be treated. The 
estimated cost of CM was highly dependent on cow traits (range: $3 $403), and 
moderately on exogenous factors. The costs of following sub optimal replacement 
policies were evaluated, such as a decision to treat all cows with CM or replacing 
all  cows  after  their  3rd  CM  case.  The  cost benefit  of  applying  two  fictitious 
vaccinations were calculated. Comparing expected net present values obtained from 
the model for cows with similar traits but differing in CM state and pregnancy 
status  can  assist  the  farmer  in  making  quantitative  economic  CM  treatment 
decisions. Current information technology as online individual cow milk recording  
systems  and  detailed  herd  management  programs  enable  individual  farm 
estimations  in  a  growing  number  of  dairy  farms.  The  developed  dynamic 
optimization and simulation model with its user interface enables gaining insight 
into disease costs under farm specific conditions. Such a model can be used by 
dairy  farmers,  bovine  practitioners,  or  extension  experts  to  assist  in  disease 
management decisions and thus improve the profitability of the enterprise. 
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CHAPTER1 
 
GENERAL INTRODUCTION 
 
Mastitis is a common disease in dairy herds in many countries (e. g. Barkema et 
al.,  1998;  Rajala Schultz  et  al.,  1999;  Sviland  and  Waage,  2002).  It  can  be  very 
detrimental to a dairy farm’s profitability, in terms of lost production and treatment 
costs (e. g. Houben et al., 1993; Seegers et al., 2003; Wilson et al., 2004). A dairy 
producer may decide it is more economical to cull a mastitic cow than to treat her, if 
her expected future net revenue is less than that from a replacement heifer. Clinical 
mastitis (CM) can be caused by different pathogens, differing in their effects (Gröhn 
et al., 2004) and treatment potential. However, the current situation is that on most 
farms and for most cases, because CM milk is not cultured, the farmer has to weigh 
treatment, culling and preventive measures options without knowledge about the CM 
causing agent. 
CM  is  often  a  recurrent  event  (e.g.  Houben  et  al.,  1993;  Döpfer  et  al.,  1999; 
Zadoks et al., 2001). In previous studies, due to the limited size of the dataset and the 
length of the observation period, only the first case of CM could be modeled, thus 
masking the possible effect of repeated CM cases (i.e. the effect of repeated cases 
could have been attributed to the first case). Repeated CM cases might have different 
effects on milk losses than the first case. 
The lack of detailed data about milk yield is currently easily resolved through the 
use of electronic cow identification systems and automatic recording of milk yield 
used  in  some  large  dairy  herds.  These  farms  also  have  accurate  events  recording, 
because  those  data  are  also  used  by  herd  personnel  to  manage  the  dairy  herd.  In  
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addition, mixed model analysis offers the opportunity to accurately describe disease 
effects (Gröhn et al., 1999).  
The bovine practitioner is often not only asked “can you fix the cow”, but “how 
much would it cost to fix her”. To answer this, relevant estimations about disease costs 
have to be determined. Static models have limited usefulness in estimating disease 
costs given the dynamics of the cow herd; dynamic models that permit modeling herd 
dynamics are much more appropriate. Such dynamic models have been developed and 
used to address herd replacement decisions in the presence of diseases (Gröhn et al., 
2003).  
Dynamic  models  of  the  cost  of  CM  are  relatively  scarce;  only  a  few  have 
addressed  mastitis  associated  costs  using  dynamic  models  (Seegers  et  al.,  2003). 
Yalcin and Stott (2000) calculated the cost benefit of whole herd mastitis preventive 
measurements  using  a  small  dynamic  programming  (DP)  model.  The  model  of 
Houben et al. (1994), used for estimating the optimal handling of mastitic cows, is 
probably the most comprehensive animal replacement DP model reported to date. The 
state  space  of  their  model  was  almost  7  million,  representing  a  large  amount  of 
realistic complexity. Several reasons encourage us to repeat and extend this seminal 
estimation effort:  
1.  New research on the effects of mastitis suggests a different model structure 
than in Houben’s model: The effect of mastitis on production (Gröhn et al., 
2004) and on the risk of culling (Gröhn et al., 2005) is time dependent. Impact 
on milk production and culling is high close to disease occurrence and tapers 
off after about 2 months. 
2.  In Houben’s model, the milk loss in the first month after CM was assumed to 
be reduced by 40% in primipara and 50% in multipara. This would result in  
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today’s high yielding dairy cow having a loss of more than 750 kg milk in the 
first month following CM. Current estimates are considerably lower (Gröhn et 
al., 2004).  
3.  The  current  milk  production  of  dairy  cows  is  about  4,000  kg  more  than 
estimated in Houben et al. (1994). In addition, there seems to be a shift in 
occurrence of mastitis causing agents (less contagious, more environmental) in 
the past 10 years in modern dairy herds. 
 
The hypothesis of this dissertation is that the cost of generic CM varies greatly for 
individual cows, depending on the performance of the cow, the lactation number, the 
stage of lactation, pregnancy status, prices, and breeding and replacement options. A 
more informed decision making process in CM management is possible through better 
understanding of these relationships. 
Using  more  current  knowledge  and  data,  the  objectives  of  this  study  are  to 
estimate  generic  CM  effects  on  production  parameters,  to  develop  an  appropriate 
dynamic model for estimating CM costs in relation to individual cow characteristics, 
to calculate expected whole herd costs, to relate these costs to exogenous parameters 
like milk price, replacement costs and pregnancy rates, and to demonstrate possible 
applications of such a model in the dairy. 
 
Outline of the dissertation: 
Chapter  2  describes  the  estimation  of  milk  losses  associated  with  multiple 
occurrences of generic CM within and across lactations in five large NewYork State 
dairy herds.  
Chapter  3  describes  the  estimation  of  the  effects  of  generic  CM  episodes  on 
mortality and culling risks in these herds.   
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Chapter 4 describes the estimation of the risk of generic CM occurrences within 
and across lactations in the study farms.  
Chapter 5 describes the dynamic optimization and simulation model constructed 
specially  to  address  repeated  CM  occurrences.  The  estimated  CM  costs  and  their 
relationship  with  exogenous  (i.e.  herd  related)  and  endogenous  (i.e.  cow  related) 
parameters are presented in this chapter.  
Chapter  6  demonstrates  real  world  application  possibilities  of  the  developed 
dynamic model, for individual cow and whole herd decision support concerning CM 
treatment options. 
Chapter  7  is  summarizes  the  main  findings  of  this  dissertation,  states  main 
reservations, and suggests future improvements of the developed framework.   
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ABSTRACT 
Our objective was to estimate the milk losses associated with multiple occurrences 
of  generic  bovine  clinical  mastitis  (CM),  within  and  across  lactations.  We  studied 
10,380  lactations  from  5  large,  high  producing,  dairy  herds  that  used  automatic 
recording  of  daily  milk  yields.  Mixed  models,  with  a  random  herd  effect  and  an 
autoregressive covariance structure to account for repeated measurements, were used 
to quantify the effect of CM, and other control variables (parity, week of lactation, 
other diseases) on milk yield. Many cows that developed CM were higher producers 
than their non mastitic herdmates before CM occurred. Milk yield began to drop after 
diagnosis; the greatest loss occurred in the first weeks, and then gradually tapered to a 
constant  value  about  2  mo  after  CM.  Mastitic  cows  often  never  recovered  their 
potential yield. First lactation cows lost 164 kg milk for the first episode and 198 kg 
for  the  second  in  the  2  mo  after  CM  diagnosis  compared  to  their  potential  yield. 
Among older cows, this estimate was 253 kg for the first, 238 kg for the second, and 
216 kg for the third CM case. A cow that had 1 or more CM episodes in her previous 
lactation produced 1.2 kg/d less milk over the whole current lactation (95% confidence 
interval:  0.6,  1.7)  than  a  cow  without  CM  in  her  previous  lactation.  The  findings 
provide dairy producers with information on the average milk loss associated with CM 
cases without considering the causative agent, and can be used for economic analysis. 
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INTRODUCTION 
Mastitis is a common disease in dairy herds in many countries (Barkema et al., 
1998;  Rajala Schultz  et  al.,  1999;  Sviland  and  Waage,  2002).  It  can  be  very 
detrimental for dairy farm profitability, because of lost production and treatment costs 
(Houben et al., 1993; Seegers et al., 2003; Wilson et al., 2004). A dairy producer may 
decide it is more economical to cull a mastitic cow than to treat her, if her expected 
future revenue is less than that from a replacement heifer. Clinical mastitis (CM) can 
be caused by different pathogens, differing in their effects (Gröhn et al., 2004) and 
treatment potential. Still, the current situation is that on most farms and for most cases, 
because  CM  milk  is  not  cultured,  the  farmer  has  to weigh  treatment,  culling,  and 
preventive measures options without knowledge about the CM causing agent. 
We  applied  the  technique  of  mixed  linear  models  to  study  the  effect  of  CM 
without specific pathogen identification on milk yield in both Finnish (Rajala Schultz 
et al., 1999) and 2 NY State (Wilson et al., 2004) dairy herds.  In the Finnish study, 
milk losses in the first 2 wk after diagnosis ranged from 1.0 to 2.5 kg /d, and the total 
loss over the entire lactation ranged from 110 to 552 kg.  In the NY study, milk losses 
due to CM in first parity cows were 5 to 7 kg/d in the first 2 wk after diagnosis, and 
690 kg over the entire lactation.  Among older cows, milk losses due to CM in the first 
2 wk following diagnosis ranged from 6 to 9 kg/d, and 570 kg over the entire lactation.  
Yet,  among  these  older  cows,  many  mastitic  cows  were  higher  producers  before 
disease onset than their non mastitic herdmates, having a potential daily advantage of 
2.6 kg.  Therefore, the total lactational loss among cows in parity 2+ (Wilson et al., 
2004) was more accurately estimated as 1,155 kg.  Thus, when studying the effect of a 
disease on milk yield, it is important to look at repeated measures of milk yield (daily, 
weekly, monthly), rather than a single summary measure for the 305 d lactational milk  
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yield (Gröhn et al., 1999), because milk yield may be higher among mastitic than non 
mastitic cows before the CM episode(s).  
Mastitis  is  often  a  recurrent  event  (Houben  et  al.,  1993;  Döpfer  et  al.,  1999; 
Zadoks et al., 2001). In our previous studies, due to the limited size of the dataset and 
the length of the observation period, only the first case of CM could be modeled, 
masking the possible effect of repeated CM cases (i.e., the effect of repeated cases 
could have been attributed to the first case). Repeated CM cases might have different 
effects on milk losses than the first case. In addition, repeated cases can cause an 
additive effect (i.e., if 2 cases are closer in time, the resultant milk loss is higher than if 
they are far apart). 
In this study, the objective was to estimate the effects of multiple occurrences of 
CM  on  milk  production  in  dairy  farms  with  high  milk  production  and  with  low 
incidence of contagious mastitis causing pathogens. 
 
MATERIALS AND METHODS 
Herd Descriptions 
The data were from 5 dairy farms, located in NY State. These farms milked an 
average of 1,200, 1,100, 750, 650 and 600 Holstein milking cows and were followed 
for approximately 18 mo. The rolling herd average was close to 11,000 kg per cow/yr 
on a 305 d basis (range 10,700 to 11,500); monthly mean SCC was 225,000 cells/mL 
(range, 180,000 to 355,000), and varied little among the 5 farms. Cows were housed in 
covered barns with concrete floors and free stalls and were classified by lactation, 
production, and reproductive status into milking groups. All groups of cows were fed 
a balanced TMR via feed alleys with headlocks that allowed restraint of cows for 
examination and treatments. Cows were milked 3 times daily. Each milking unit had 
milk meters capable of automatically recording milk production and (in 2 farms) milk  
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conductivity. Most cases of CM were identified by milkers (warm, swollen udder or 
changes  in  the  milk  consistency),  while  others  were  detected  by  the  herdsperson 
examining cows whose milk electrical conductivity had increased 30% above their last 
10  d  mean  (Afimilk®,  SAE  Afikim,  Israel)  or  had  a  concurrent  drop  in  milk 
production (on most farms this was set to 30% below their average milk yield). Sick 
cows  were  treated  according  to  well defined  protocols  that  were  similar,  but  not 
completely the same in all farms, and throughout the study (one farm also treated 
Gram  negative  CM  cases  with  antibiotics  in  the  first  months  of  the  study).  Farm 
personnel  used  DairyComp305®  herd  management  software  (Valley  Agricultural 
Software, Tulare, CA) to record lactation, reproductive, and medical data for each 
cow.  Information  on  parity,  diseases,  drying off,  calving,  and  culling  was  readily 
available. 
Case Definition 
  All lactating cows in the 5 study herds were eligible for inclusion as cases of CM.  
Training and standardization concerning CM detection was provided at the beginning 
of the study. Although we were specifically interested in the milk loss associated with 
CM  without  knowledge  of  the  causative  agent,  farm  personnel  sampled  milk  for 
microbiological culture from quarters with signs of CM. The samples were collected 
daily and were cultured by the Quality Milk Production Services laboratories. The 
bacteriological culture procedures are described in detail in Gröhn et al. (2004).  
Some cows had 2 clinical episodes in the same quarter within several days of each 
other. Any such episode that occurred within 5 d, or occurred within 14 d with the 
same etiologic agent isolated from both occurrences, was considered the same case of 
mastitis. Any episode that occurred more than 14 d after the previous episode was 
considered a new CM case.    
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Other Diseases 
While focusing on CM, we chose 6 other diseases for inclusion in the models as 
potential  confounders.    These  diseases  are  among  the  most  common  clinical 
conditions that are universally a problem in dairy cows and reliable information about 
their occurrence was present in the dataset for all farms. The rationale for choosing 
them is that they may cause milk loss, in addition to the effects of CM. 
The additional 6 recorded diseases were milk fever, retained placenta, metritis, 
ketosis, displaced abomasum (DA), and pneumonia.  They were defined as follows 
(Wilson et al., 2004): a) milk fever occurred if a cow was unable to rise or had cool 
extremities  and  sluggish  rumen  motility  near  the  time  of  calving,  but  was  treated 
successfully with calcium;  b) retained placenta was retention of fetal membranes for 
at  least  24  hrs  post calving;    c)  metritis  involved  a  febrile  state  accompanying  a 
purulent or fetid vaginal discharge, or a diagnosis of an enlarged uterus by veterinary 
palpation;  d) ketosis was diagnosed by detection of ketones in milk or urine, and 
response to treatment;  e) DA occurred when the abomasum was enlarged with fluid, 
gas,  or  both,  and  was  mechanically  trapped  in  either  the  left  or  right  side  of  the 
abdominal cavity.  Nearly every DA was confirmed by surgery;  f) pneumonia was 
diagnosed  by  the  presence  of  pathological  breathing  sounds  (using  a  stethoscope). 
Every effort was taken to ensure that disease definition and diagnostic criteria were the 
same in all herds.  Written disease definitions were provided to the dairy producers 
and veterinarians involved. 
 
Statistical Methods 
The SAS procedure PROC MIXED (SAS Institute, Inc., 2006) was used to study 
the effects of the CM and control variables, herd, parity, week in milk (WIM), and 
other diseases, on weekly averaged milk yield in 10,380 lactations. Because we were  
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not  interested  in  an  individual  farm,  but  rather  the  farms  in  general  with  these 
characteristics  (i.e.,  large,  high  milk  producing  dairy  farms  with  low  incidence  of 
contagious  mastitis),  herd  was  modeled  as  a  random  (intercept)  effect.  The  other 
covariates were modeled as fixed effects. 
The outcome variable, weekly averaged milk yield was calculated by adding the 
milk weights of the 3 daily milkings.  Then, within each week of lactation, the 7 daily 
values were summed, and divided by 7, to give the mean daily milk yield for the 
particular week in lactation.  Randomly occurring zero values for a particular milking 
were filled using the weekly average value for the particular milking. We used weekly 
average milk yields over daily measurements because the latter made the size of the 
dataset unsolvable using available hardware, and did not deliver statistical efficacy 
because daily milk yields had a larger variance.  
The dataset contained repeated measurements of milk  yield  within a cow over 
lactation, and these were correlated with one another. This correlation was corrected 
for in the regression model by specifying a correlation structure among the repeated 
measurements (R matrix). In previous work, the first order autoregressive correlation 
structure was found optimal for this purpose (Wilson et al., 2004); therefore, it was 
used in the current analysis.   
Parity  was  divided  into  2  groups,  which  were  analyzed  separately:  first,  and 
second and higher; within the older group, parity was further subdivided into parities 
2, 3, 4, 5, 6, and 7. Older cows (> parity 7) were not analyzed because of low number 
of observations. Milk yields were modeled for the first 51 wk of lactation.  
The first 3 episodes of CM during the current lactation and a carry over effect of 
CM in the previous lactation were studied; the other diseases controlled for in the 
models were retained placenta, milk fever, metritis, DA, ketosis, and pneumonia.   
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An index variable for each CM episode was created to classify the milk weights 
according to when they were measured in relation to disease occurrence. This enabled 
precise determination when a disease had an effect on milk yield. After initial data 
analysis,  these  indices  were  collapsed  as  follows:  before  diagnosis,  same  week  as 
disease  diagnosis,  1,  2,  3,  4,  5,  6,  7,  and  >8  wk  after  diagnosis.  The  same  index 
scheme was used for the other 6 diseases.  
Several carry over effects across lactations were studied. In the final model the 
simple definition of having any CM occurrence in the previous lactation or not, was 
preferred over more complex definitions. 
Herd was modeled as a random effect. It was chosen over other possible random 
effects after initial data analysis, based on the Akaike’s information criterion (AIC) as 
a measure of goodness of fit (Wilson et al., 2004).  
For parity 2+ cows, the following linear mixed model was used: 
Y = Parity (6 index variables) + WIM (50 index variables) + Milk fever (9 
index  variables)  +  Retained  placenta  (9  index  variables)  +  Metritis  (10 
index variables) + DA (10 index variables) + Ketosis (10 index variables) + 
Pneumonia (10 index variables) + 1
st CM in the current lactation (10 index 
variables) + 2
nd CM in the current lactation (9 index variables) + 3
rd CM in 
the current lactation (9  index variables)  + CM  in the previous lactation 
(0/1) + Herd (random) + e;            [1] 
where  Y  is  the  mean  milk  yield  per  day  in  a  particular  week  of  lactation,  the 
independent variables are as defined above, and e is a complex error term representing 
within cow correlation of milk weights and residual error. For parity 1 cows, the same 
model was used, except that the terms for parity, CM in the previous lactation, and 
milk fever were omitted, as they were not applicable. The reference cow was always a 
cow free of that disease at the time of milk measurement. This parameterization (3 sets  
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of covariates: 1 for each CM occurrence) assumes an additive carry over effect of the 
previous CM case on the current CM milk loss. For example, if a cow had her second 
CM case 4 wk after the first case, in this week, her milk yield was assumed the sum of 
the effect the first case caused (i.e., 4 wk after first CM), and the milk loss associated 
with the same week of the second CM case.  
Primipara and multipara were analyzed separately, because of the greatly differing 
shapes of their lactation curves and a possibly different CM effect. After restricting the 
lactation follow up period to the first 50 WIM in the mixed model analysis, there were 
3,681 parity 1 cows and 6,699 parity 2+ cows.  In the analysis on parity 1 cows, there 
were 112,475 weekly milk weights used.  In the analysis on parity 2+ cows, there were 
192,691 weekly observations used. 
To represent a CM effect regardless of the time of occurrence of the previous CM, 
the parameterization of the CM was changed so that only one index (M) was used to 
represent the time of the milk measurement in relation to the time of CM occurrence. 
For parity 2+ cows the following linear mixed model was used: 
Y = Parity (6 index variables) + WIM (50 index variables) + Milk fever (9 
index variables) + Retained placenta (9 index variables) + Metritis (10 index 
variables)  +  DA  (10  index  variables)  +  Ketosis  (10  index  variables)  + 
Pneumonia (10 index variables) + CM in the current lactation (28 index 
variables) + CM in the previous lactation (0/1) + Herd (random) + e;        [2] 
where all terms are identical to the previous model except for the representation of the 
current  lactation  CM  effects.  This  parameterization  (1  covariate  with  28  index 
variables expressing when the milk weights were measured in relation to the first 3 
CM cases), assumes that the losses observed were associated with this particular CM 
occurrence  without  adjusting  the  losses  potentially  due  to  the  previous  CM.  For 
example, if a cow had her second CM case 4 wk after the first case, in this week, her  
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milk loss was modeled as the milk loss associated with the second CM case without 
separately modeling her previous CM history. Table 2.1 illustrates the different coding 
used for Model [1] (M1, M2, and M3) vs. Model [2] (M). The reference cow was 
always a cow free of that disease in the time of milk measurement.  
 
Table 2.1. Data for an example cow with 2 clinical mastitis (CM) cases illustrating the 
2 covariate coding schemes used in the statistical analysis of this study 
 
Week 
in milk 
Week of 
1
st CM 
case 
Week of 
2
nd CM 
case 
Index variable 
for 1
st CM 
case (M1)
1 
Index 
variable for 
2
nd CM case 
(M2)
1 
Index variable 
for both CM 
cases (M)
2 
11  13  17  1  111  1 
12  13  17  1  111  1 
13  13  17  2  111  2 
14  13  17  3  111  3 
15  13  17  4  111  4 
16  13  17  5  111  5 
17  13  17  6  2  12 
18  13  17  7  3  13 
19  13  17  8  4  14 
20  13  17  9  5  15 
21  13  17  10  6  16 
 
1Used in Model [1]: Y = Parity + Week in milk + Milk fever + Retained placenta + 
Metritis  +  Displaced  abomasum  +  Ketosis  +  Pneumonia  +  1
st  CM  in  the  current 
lactation (10 index variables) + 2
nd CM in the current lactation (9 index variables) + 
3
rd CM in the current lactation (9 index variables) + CM in the previous lactation + 
Herd (random) + e 
The index variables indicated when milk weights were measured in relation to CM 
occurrence. 1: before first CM; 2: week of CM occurrence; 3: second week after CM 
occurrence;  4:  third  week  after  CM  occurrence;  .  .  .;  10:  ninth  week  after  CM 
occurrence; 111: reference level (free of CM at this time of milk measurement). 
2Used in Model [2]: Y = Parity + Week in milk + Milk fever + Retained placenta + 
Metritis + Displaced abomasum + Ketosis + Pneumonia + CM in the current lactation 
(28 index variables) + CM in the previous lactation + Herd (random) + e 
The index variables indicated when milk weights were measured in relation to CM 
occurrence. 1: before first CM; 2: week of first CM occurrence; 3: second week after 
first CM occurrence; 4: third week after first CM occurrence; 5: fourth week after first 
CM occurrence; 12: week of second CM occurrence; 13: second week after second 
CM occurrence; 14: third week after second CM occurrence; 15: fourth week after 
second CM occurrence; 16: fifth week after second CM occurrence. 
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To calculate the milk losses associated with CM, the potential milk yield of a 
CM  cow  was  defined  as  if  she  would  keep  her  pre diseased  milk  yield  level 
throughout the lactation. Therefore, the milk loss associated with CM was compared 
to  her  pre disease  level  (corrected  for  the  other  covariates).  To  calculate  the 
cumulative milk losses associated with CM, the milk yield losses of a CM diseased 
cow were summed as if she would get CM at the median day for each of the CM 
occurrences. All first CM cases were taken for the estimation of the first case; the 
same was true for the second CM case. The data were not stratified by number of CM 
occurrences within lactation because at the time of CM the farmer does not know if 
this case will be followed by another. 
The  incidences  of  the  diseases  modeled  were  calculated  as  lactational 
incidence risks (LIR), i.e., the probability of a cow having the disease in 1 lactation. 
 
RESULTS 
Descriptive Findings 
Table  2.2  gives  the  number,  LIR,  and  median  WIM  of  occurrence  for  the 
diseases  present.  The  LIR  of  the  first  CM  episode  in  multipara  was  twice  that  in 
primipara  (P  <  0.0001).  LIR  for  subsequent  CM  cases  were  higher  in  multipara 
compared to primipara (P < 0.0001). The median WIM (13 WIM) for the first CM 
episode was the same in both age groups. Nevertheless, a second CM case occurred 
sooner for multipara (20 WIM), and later for primipara (26 WIM) (P < 0.0001). The 
same trend was observed for a third CM case. 
The LIR of retained placenta was nearly 2 times higher in multipara compared 
to primipara (P < 0.0001); the opposite was true for metritis (P < 0.0001). The LIR for 
other diseases studied were comparable in both groups of cows. The median WIM for  
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all non CM diseases studied, except for pneumonia, was very early in lactation (1 to 2 
WIM).  
 
Table 2.2. Number of cases, lactational incidence risk (LIR), and median week at 
occurrence (WIM) for the first 3 clinical mastitis (CM) cases and the other 6 diseases 
controlled for in the model analyzing the effect of CM on milk yield 
 
    Primipara  Multipara 
    n 
LIR 
(%)  WIM  n 
LIR 
(%)  WIM 
Cows    3,681      6,699     
First CM    448  12  13  1,639  24  13 
Second CM  87  2  26  551  8  20 
Third CM    24  1  35  216  3  27 
Milk fever    NA
1  NA  NA  137  2  1 
Retained placenta  216  6  1  745  11  1 
Metritis    287  8  2  267  4  1 
Ketosis    166  5  2  488  7  2 
Displaced abomasum  101  3  2  265  4  2 
Pneumonia  106  3  8  165  2  14 
1NA = Not Applicable 
 
Although  we  did  not  model  the  mastitis  causing  pathogens  separately,  the 
bacteriological results of the samples taken at the time of CM are presented in Table 
2.3. The vast majority of CM cases were environmental bacteria (P < 0.0001), with 
Escherichia  coli,  Streptococcus  spp.,  ‘No  Growth’  (i.e.,  fewer  than  2  colonies  per 
plate), and Klebsiella the most common findings.  
  The number of real repeated cases caused by the same pathogen (detailed data 
not shown) was of interest. Following our definition of recurrent CM cases, 40% of 
second cases were due to the same pathogen as in the first case, and 51% of third cases 
were due to the same pathogen as in the first or second case. 
  The estimated lactation curves for the first 305 DIM are graphically presented 
for  primiparous  cows  in  Figure  2.1  and  for  multiparous  cows  in  Figure  2.2.  The 
estimated effect of parity was 1.2, 0.3, 0.0,  2.1, and  3.4 kg milk for parity 3, 4, 5, 6, 
and 7, respectively, compared to a cow in her second lactation. Standard errors for  
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these estimates were 0.15, 0.18, 0.24, 0.37, and 0.57 kg milk, respectively.   
 
Table 2.3. Pathogens isolated from milk of the first, second, and third case of clinical 
mastitis (CM) 
    Primipara    Multipara 
    1
st CM  2
nd CM 
3
rd 
CM    1
st CM  2
nd CM  3
rd CM 
# of cases    448  87    24    1639  551  216 
Escherichia coli  27%  23%  29%    29%  21%  18% 
Klebsiella    5%  6%  4%    11%  13%  18% 
No Growth
1  10%  14%  21%    18%  21%  25% 
Streptococcus spp.  18%  24%  13%    18%  19%  17% 
Staphylococcus aureus  6%  0%  4%    4%  5%  6% 
CNS    4%  2%  4%    2%  2%  2% 
A. pyogenes  2%  2%  4%    1%  2%  1% 
Yeast    4%  6%  0%    1%  1%  0% 
Other
2    6%  10%  4%    4%  5%  3% 
Undefined
3    18%  13%  17%    11%  12%  9% 
 
1Fewer than 2 colonies per plate 
2Any organism not specified above 
3More than 3 different organisms isolated (i.e., contaminated sample) 
 
Estimates of Milk Loss associated with CM 
Estimates  for  the  effects  of  the  first  3  occurrences  of  CM  are  given  for 
primiparous (Table 2.4) and multiparous (Table 2.5) cows for the parameterization 
described  in  Model  [1].  The  same  estimates  are  given  for  the  alternative 
parameterization (Model [2]) in Tables 2.6 and 2.7, respectively. The  estimates of 
repeated CM cases from Model [2] are generally slightly higher. Model [2] resulted in 
a better model fit (P < 0.0001). The AIC in primipara decreased to 564,717 from 
572,300, and in multipara the AIC of Model [2] was 1,085,058 vs. 1,090,422 in Model 
[1]. For incorporation of these results into an economic model, the parameterization of 
Model [2] was simpler (because no memory variables for previous CM cases were 
needed). Therefore, in the following presentation, only the results of Model [2] are 
discussed.  
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Table 2.4. Effects of the first 3 occurrences of generic clinical mastitis (CM) on milk 
yield in 3,681 Parity 1 cows in 5 NY State dairy farms; estimates were obtained from 
a mixed model with an autoregressive covariance structure and random herd effect. 
CM episodes were allowed to have simultaneous effects in the same time period. 
Values are kg/d of milk. 
Relative time
1  1
st CM  2
nd CM  3
rd CM 
      Est.
2  95% CI      Est.
2  95% CI      Est.
2  95% CI 
Before CM  0.7  0.3  1.0                   
Same week   3.8   4.2   3.4   4.8   5.5   4.1   1.8   3.2   0.4 
+1 week   3.8   4.3   3.3   3.9   4.9   2.9   1.3   3.1  0.5 
+2 weeks   2.5   3.1   2.0   2.4   3.5   1.2  0.6   1.5  2.7 
+3 weeks   1.7   2.2   1.1   2.1   3.3   0.9  0.5   1.7  2.8 
+4 weeks   1.2   1.7   0.6   2.2   3.4   0.9   0.1   2.5  2.2 
+5 weeks   0.9   1.5   0.3   1.5   2.8   0.3   0.6   2.9  1.7 
+6 weeks   1.2   1.7   0.6   1.6   2.8   0.3  0.5   1.8  2.8 
+7 weeks   1.0   1.5   0.5   1.2   2.4  0.0  2.0   0.2  4.1 
+8 and after   1.0   1.5   0.6   0.4   1.4  0.6  2.0  0.2  3.8 
1Time of milk measurement in relation to disease occurrence 
2CI = Confidence Interval 
 
 
Table 2.5. Effects of the first 3 occurrences of generic clinical mastitis (CM) on milk 
yield in 6,699 Parity 2+ cows in 5 NY State dairy farms; estimates were obtained from 
a mixed model with an autoregressive covariance structure and random herd effect. 
CM episodes were allowed to have simultaneous effects in the same time period. 
Values are kg/d of milk. 
Relative time
1  1
st CM  2
nd CM  3
rd CM 
      Est.
2  95% CI      Est.
2  95% CI      Est.
2  95% CI 
Before CM  1.8  1.5  2.1                 
Same week   4.8   5.2   4.5   4.2   4.5   3.8   3.1   3.7   2.5 
+1 week   6.0   6.4   5.6   5.0   5.5   4.5   4.2   5.0   3.5 
+2 weeks   3.6   4.0   3.2   2.9   3.4   2.3   2.8   3.7   1.9 
+3 weeks   2.4   2.8   2.0   1.9   2.5   1.3   2.1   3.1   1.1 
+4 weeks   1.6   2.0   1.2   1.5   2.1   0.8   1.6   2.7   0.6 
+5 weeks   1.0   1.4   0.6   0.9   1.6   0.3   0.9   2.0  0.1 
+6 weeks   0.5   0.9   0.1   0.5   1.1  0.2   0.8   1.8  0.2 
+7 weeks  0.0   0.3  0.4  0.0   0.6  0.6   0.1   1.1  0.8 
+8 and after  0.0   0.3  0.3  0.0   0.5  0.5   0.1   0.9  0.7 
 
1Time of milk measurement in relation to disease occurrence; 
2CI = Confidence 
Interval 
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Table 2.6. Effects of the first 3 occurrences of generic clinical mastitis (CM) on milk 
yield in 3,681 Parity 1 cows in 5 NY State dairy farms; estimates were obtained from 
a mixed model with an autoregressive covariance structure and random herd effect. 
CM episodes were not allowed to have simultaneous effects in the same time period. 
Values are kg/d of milk. 
Relative time
1  1
st CM  2
nd CM  3
rd CM 
      Est.
2  95% CI      Est.
2  95% CI      Est.
2  95% CI 
Before CM  0.7  0.3  1.0                   
Same week   3.8   4.3   3.4   5.8   6.6   5.0   2.9   4.6   1.2 
+1 week   3.8   4.3   3.3   4.5   5.5   3.5   1.9   3.9  0.1 
+2 weeks   2.6   3.1   2.0   2.9   4.1   1.8  0.4   1.8  2.6 
+3 weeks   1.9   2.5   1.4   2.5   3.7   1.3  1.2   1.1  3.4 
+4 weeks   1.7   2.3   1.1   2.6   3.9   1.3  0.5   1.8  2.9 
+5 weeks   1.4   2.0   0.8   2.1   3.5   0.7  0.7   1.6  3.0 
+6 weeks   1.5   2.1   0.9   1.5   3.0   0.1  1.0   1.3  3.4 
+7 weeks   1.1   1.7   0.6   1.0   2.4  0.4  1.6   0.5  3.8 
+8 and after   1.4   1.9   0.9   0.1   1.3  1.2  1.0   0.8  2.8 
1Time of milk measurement in relation to disease occurrence 
2CI = Confidence Interval 
 
 
Table 2.7. Effects of the first 3 occurrences of generic clinical mastitis (CM) on milk 
yield in 6,699 Parity 2+ cows in 5 NY State dairy farms; estimates were obtained from 
a mixed model with an autoregressive covariance structure and random herd effect. 
CM episodes were not allowed to have simultaneous effects in the same time period. 
Values are kg/d of milk. 
Relative time
1  1
st CM  2
nd CM  3
rd CM 
      Est.
2  95% CI      Est.
2  95% CI      Est.
2  95% CI 
Before CM  1.7  1.4  2.1                 
Same week   4.9   5.2   4.5   5.6   6.1   5.1   4.2   5.0   3.5 
+1 week   5.9   6.3   5.6   5.9   6.4   5.3   4.8   5.7   3.9 
+2 weeks   3.7   4.1   3.3   3.6   4.2   3.0   3.0   4.0   2.0 
+3 weeks   2.5   3.0   2.1   2.3   3.0   1.6   2.1   3.1   1.0 
+4 weeks   2.0   2.4   1.5   1.5   2.2   0.8   1.5   2.5   0.4 
+5 weeks   1.5   2.0   1.0   0.8   1.5  0.0   0.8   1.9  0.3 
+6 weeks   1.0   1.5   0.6   0.4   1.2  0.4   0.6   1.6  0.5 
+7 weeks   0.7   1.1   0.2  0.0   0.8  0.7   0.1   1.1  0.9 
+8 and after   0.7   1.1   0.2  0.3   0.4  1.0  0.0   0.8  0.8 
 
1Time of milk measurement in relation to disease occurrence 
2CI = Confidence Interval 
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  In  mastitic  primipara,  the  greatest  milk  losses  occurred  immediately  after 
diagnosis of CM (Table 2.6). In the first 7 wk after diagnosis of the first and second 
CM cases in primipara, milk yield in mastitic cows remained well below (P < 0.01) 
that of non CM cows (see 95% confidence intervals (CI)). For a third episode, in 
contrast, milk loss (P < 0.001) occurred only in the same week of diagnosis (this 
estimate was based on only 24 cases); therefore the effect of the third CM case in 
primipara was not considered in the following discussion. After their first CM case, 
primiparous  cows  were  producing  less  milk  (P  <  0.0001)  than  their  non CM 
herdmates, even after more than 8 wk after CM diagnosis. In addition, before the first 
CM  episode,  mastitic  primipara  actually  outproduced  (P  <  0.001)  their  non CM 
herdmates, by 0.7 kg/d.  
  Figure  2.1  graphically  displays  the  information  obtained  by  the  statistical 
model (Model [2]). Although mastitic primipara had a slight production advantage 
before CM diagnosis (0.7 kg/d, 95% CI: 0.3, 1.0), this soon vanished upon diagnosis. 
The milk yield of mastitic cows remained well below (P < 0.0001) that of their non 
CM herdmates, and dropped further with a subsequent episode. Figure 2.1 displays the 
potential  lactation  curve  of  the  mastitic  cows,  if  they  had  not  contracted  CM. 
Compared to CM free cows, the first CM episode was associated with a milk loss of 
126 kg in the first 2 mo, and the second episode with 160 kg. Considering the potential 
milk yield of CM diseased cows, these cows lost 164 and 198 kg milk in the 2 mo 
after the first and second CM episodes, respectively.   
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Figure 2.1. Effect of clinical mastitis (CM) on the lactation curve of primiparous 
cows (least squares means from 3,681 lactations). The solid line with filled circles 
represents a cow with 2 CM occurrences (Generic); the dashed line with open squares 
represents a cow without CM (Healthy). The arrows indicate median weeks in milk of 
CM. The dotted line portrays the estimated lactation curve of the CM diseased cow if 
she had remained CM free (Potential). Standard errors for these estimates (first 43 
dummy variables) were in the range of 0.16 to 0.17 kg milk in primipara. 
 
In multiparous cows (Table 2.7), before CM, cows that would go on to develop 
this disease were producing 1.7 kg/d more milk than their non mastitic herdmates. 
Once CM had occurred the picture changed markedly. For the first episode, milk loss 
(P < 0.0001) occurred for 6 wk after diagnosis. For second and third episodes, milk 
loss (P < 0.0001) continued for 5 and 4 wk, respectively. Within each episode, milk 
loss  was  greatest  immediately  after  diagnosis,  and  then  tapered  off  in  subsequent 
weeks, until production returned nearer to levels of non CM cows. Nonetheless, as 
seen in Figure 2.2 (results from Model [2]), even by the end of lactation, production of 
CM cows remained well below (P < 0.0001) that of their potential. Compared by  
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direct contrast, cows suffering from their 3
rd CM case tended to have a slightly less 
severe milk drop (p<0.1). After their first CM case, multiparous cows were producing 
substantially less milk (P < 0.0001) than their non CM herdmates, even after more 
than 8 wk after CM diagnosis. Compared to CM free cows, the first CM episode was 
associated with a milk loss of 156 kg in the first 2 mo, the second episode with 141 kg, 
and the third with 119 kg. Considering the higher potential milk yield of CM diseased 
cows (1.7 kg/d), these cows lost 253, 238, and 216 kg milk for the above period and 
cases, respectively.  
If a cow experienced CM in her previous lactation, she produced less milk in 
her subsequent lactation. We estimated this effect as 1.2 kg/d over the whole lactation 
(95% CI: 0.6, 1.7). There were no substantial differences (P > 0.05) either by number 
of occurrences of CM or by the time when CM occurred in the previous lactation (data 
not shown). 
Estimates of Milk Loss associated with other Diseases 
  In addition to CM, retained placenta, metritis, ketosis, DA, and pneumonia all 
reduced milk yield (P < 0.05) in primipara (Table 2.8). All of these diseases, except 
for retained placenta, which can only occur right after calving, were associated with 
lower  production  (P  <0.05)  even  before  they  were  diagnosed.  Retained  placenta 
continued  to  have  a  negative  effect  (P  <  0.0001)  on  production  throughout  the 
lactation period evaluated. Metritic and DA diseased primipara produced less milk (P 
< 0.0001) than their herdmates for 5 wk after diagnosis (and treatment). Pneumonia 
had a negative effect (P < 0.0001) on production until 7 to 8 wk after diagnosis. Milk 
losses associated with ketosis continued for about a month after diagnosis, at which 
time ketotic cows began to outproduce their non ketotic herdmates (P < 0.001). 
  Milk loss (P < 0.05) in multipara was associated with all diseases modeled  
  25 
(Table 2.9), in addition to that seen with CM. Milk loss (P < 0.0001) occurred even 
before diagnosis for metritic and DA diseased multiparous cows. Losses associated 
with retained placenta, metritis, DA, and pneumonia continued for at least 7 to 8 wk 
after diagnosis; they were especially large (P < 0.0001) for DA, in which case the 
effect lasted throughout the lactation. Losses associated with ketosis were evident until 
5 to 6 wk after diagnosis (P < 0.0001). Milk fever diseased cows produced less milk 
in the first 2 wk after calving, but greatly (P < 0.01) outproduced their herdmates later 
in lactation.  
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Figure 2.2. Effect of clinical mastitis (CM) on the lactation curve of multiparous cows 
(least squares means from 6,699 lactations). The solid line with filled circles 
represents a cow in the second lactation with 3 CM occurrences (Generic); the dashed 
line with open squares represents a cow in the second lactation without CM (Healthy). 
The arrows indicate median weeks in milk of CM. The dotted line portrays the 
estimated lactation curve of the CM diseased cow if she had remained CM free 
(Potential). Standard errors for these estimates (first 43 dummy variables) were in the 
range of 0.18 to 0.19 kg milk in multipara. 
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Table 2.8. Effects of 5 other diseases on milk yield in 3,681 Parity 1 cows in 5 NY State dairy farms; estimates were obtained from 
a mixed model with an autoregressive (order 1) covariance structure and random herd effect. Values are kg/d of milk. 
Retained placenta  Metritis  Ketosis  Displaced abomasum  Pneumonia  Time of milk 
measurement
1  Est.  95% CI
2  Est.  95% CI  Est.  95% CI  Est.  95% CI  Est.  95% CI 
Before            3.0   3.8   2.2   0.7   1.5  0.0   4.1   4.9   3.3   1.4   2.1   0.6 
Same week   7.3   8.1   6.6   3.2   3.8   2.6   2.2   3.0   1.5   11.1   12.0   10.1   7.3   8.2   6.4 
+1 wk   3.7   4.6   2.9   2.3   3.0   1.7   1.4   2.2   0.6   8.5   9.6   7.5   5.5   6.5   4.5 
+2 wk   2.8   3.6   1.9   2.2   2.9   1.6   0.9   1.7  0.0   7.0   8.1   5.9   4.4   5.4   3.3 
+3 wk   2.6   3.4   1.8   1.7   2.3   1.0   0.3   1.1  0.6   5.7   6.8   4.6   4.3   5.4   3.2 
+4 wk   2.4   3.2   1.6   1.2   1.8   0.5  0.4   0.5  1.2   4.3   5.4   3.2   3.2   4.3   2.1 
+5 wk   1.9   2.6   1.1   0.8   1.5   0.2  1.0  0.2  1.9   2.5   3.6   1.4   3.0   4.1   1.9 
+6 wk   1.5   2.2   0.8   0.1   0.7  0.5  1.4  0.6  2.2   1.0   2.0  0.1   2.5   3.6   1.5 
+7 wk   1.2   1.9   0.6  0.1   0.4  0.7  1.8  1.1  2.5  0.1   0.9  1.0   1.4   2.4   0.4 
+8 wk and after   0.6   1.1   0.1  0.5  0.1  0.9  1.8  1.2  2.4  0.7   0.2  1.5  0.0   0.9  0.8 
1Relative to disease recording 
2CI = Confidence Interval 
 
Table 2.9. Effects of 6 other diseases on milk yield in 6,699 Parity 2+ cows in 5 NY State dairy farms; estimates were obtained 
from a mixed model with an autoregressive (order 1) covariance structure and random herd effect. Values are kg/d of milk. 
  Milk fever  Retained placenta  Metritis  Ketosis  Displaced abomasum  Pneumonia 
  Est.  95% CI
2  Est.  95% CI  Est.  95% CI  Est.  95% CI  Est.  95% CI  Est.  95% CI 
Before               3.6   4.7   2.4  0.2   0.5  0.8   6.4   7.2   5.7   0.1   0.9  0.8 
Same week   2.1   3.4   0.8   10.6   11.2   10.0   6.2   7.0   5.3   3.3   3.9   2.6   15.5   16.3   14.6   8.0   9.0   7.0 
+1 wk   2.0   3.4   0.5   7.2   7.8   6.5   4.5   5.4   3.6   3.7   4.3   3.0   12.4   13.3   11.5   6.6   7.7   5.5 
+2 wk   2.1   3.5   0.7   4.8   5.5   4.2   4.1   5.0   3.2   2.5   3.2   1.8   10.5   11.4   9.5   4.8   6.0   3.6 
+3 wk   0.5   1.9  0.9   3.5   4.2   2.9   3.3   4.2   2.4   1.9   2.6   1.2   8.4   9.3   7.4   4.9   6.2   3.6 
+4 wk   0.6   2.0  0.8   3.0   3.6   2.4   2.2   3.2   1.3   1.4   2.1   0.6   6.3   7.3   5.4   4.3   5.6   3.0 
+5 wk  0.4   1.0  1.7   2.1   2.7   1.5   1.7   2.6   0.8   0.9   1.6   0.2   5.2   6.1   4.2   3.3   4.6   2.0 
+6 wk  1.1   0.1  2.4   1.3   1.9   0.8   1.4   2.2   0.6   0.5   1.1  0.2   4.0   4.9   3.1   2.4   3.6   1.1 
+7 wk  1.6  0.4  2.7   0.6   1.1   0.1   1.2   1.9   0.4   0.2   0.8  0.4   3.0   3.8   2.2   1.3   2.4   0.1 
+8 wk and after  1.6  0.7  2.5   0.1   0.5  0.3   0.2   0.8  0.4   0.2   0.7  0.3   1.9   2.6   1.2   0.5   1.5  0.6 
1Relative to disease recording 
2CI = Confidence Interval  
2
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DISCUSSION 
Our  main  objective  was  to  estimate  the  milk  loss  associated  with  repeated 
occurrences of CM in high producing dairy cows. The findings indicated that CM is 
frequently a recurrent event, especially in multiparous cows. The same causative agent 
was involved in fewer than half of the repeated CM cases.  The milk loss associated 
with repeated CM cases was slightly less severe than that caused by the first CM case.  
We  purposely  chose  to  study  large,  high  producing  dairy  herds,  with  low 
incidences of contagious mastitis pathogens, as these are the farms that produce most 
of the milk in industrial countries. The incidence of CM in our sample herds, and the 
estimated milk loss associated with this disease, demonstrate that despite the success 
of  control  programs  against  contagious  mastitis  pathogens,  CM  remains  a  serious 
economically limiting disease in the dairy industry. CM affects cows that generally 
have  high  milk  production  potential.  This  finding  is  in  agreement  with  previous 
studies (Seegers et al., 2003; Wilson et al., 2004). It also has a long term effect on 
future milk production. In the current study even 1 CM episode in the lactation was 
associated with a loss of about 400 kg milk in the next lactation. Houben et al. (1993) 
found  this  carry over  effect  only  after  3  and  more  CM  episodes,  but  their  study 
involved cows producing only 7,000 kg of milk per lactation and only about 500 CM 
cases (vs. over 3,000 cases).   
Several parameterization schemes for estimating repeated CM cases were possible. 
We  presented  2  and  prefer  the  CM  coding  scheme  where  the  carry over  effect  of 
previous CM case(s) was included in the current CM (Model [2]), because it results in 
a better model fit and is simpler to implement in economic models.  
Taking  into  account  the  higher  milk  production  of  cows  before  the  first  CM 
episode and the long term milk loss of the first case, the effect of subsequent CM  
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episodes on milk production was less severe than that caused by the first case. Several 
explanations  of  this  effect  are  feasible.  Bradley  and  Green  (2001)  postulated  that 
agents with less pathogenicity are more likely involved in repeated cases. These more 
“udder adaptive” agents, after a CM episode has occurred, are not completely cleared 
from  the  udder.  They  may  exist,  for  some  time,  at  undetectable  (by  standard 
bacteriological  culture  techniques)  levels.  Then,  e.g.,  if  the  cow  experiences  some 
stress at a later date, levels of these pathogens may rise above the detection threshold, 
and even cause symptoms of CM, thus resulting in a repeated CM case. Such an effect 
could be a result of acquired immunity after a first CM case (Paape et al., 2002), 
leading  to  a  less  severe  response  (at  least  in  milk  yield)  in  subsequent  episodes. 
Another possible explanation of this decreasing effect is that the milk loss is relative 
and not absolute. This theory can explain why our estimates are higher than those 
found  in  lower  producing  cows  (Rajala Schultz  et  al.,  1999).  Transforming  our 
estimates into percentage of the actual milk yield, the estimates of both studies, and 
the effect of repeated cases, makes our results more similar.  
A  third  explanation  is  that  observational  studies  made  in  commercial  herds 
inevitably suffer from various selection and misclassification biases (Kleinbaum et al., 
1982). A selection bias will be present because cows suffering from high milk losses 
after CM were culled as a result of low production, so that the resulting CM milk loss 
is actually biased toward the null. This is especially so for the repeated CM cases. A 
misclassification bias is present if a CM cow was not diagnosed as such. In this case 
we attributed the effect of undetected CM cases to the long term milk loss of the 
previous  case.  The  exceptionally  large  dataset  needed  to  estimate  repeated  CM 
episodes’ effects makes the wish to do such estimations in research herds (with a 
forced “no cull” policy) a prohibitively costly escapade. 
The milk losses obtained in this study are slightly less for the first case of CM than  
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those found in 2 other NY State dairy herds of comparable production level (Wilson et 
al., 2004). A reason for the discrepancy is because in the previous study the effect of 
repeated  cases  was  attributed  to  the  first  CM  case.  Repeated  cases  occurred  in 
approximately 30% of cows with a first CM case; hence this more correct production 
loss accounting is quite substantial.  
Although we included other production diseases only as potential confounders in 
our models, the fact that we had daily milk yield records, the size of the study dataset, 
and  the  statistical  procedure  used,  make  the  estimated  milk  losses  associated  with 
these diseases of valuable contribution in evaluating their economical importance.    
As estimation about the effects of repeated CM were rarely addressed in previous 
studies, the current study about the milk losses associated with repeated CM episodes 
is an important step forward in helping dairies assess the profitability of individual 
cows, as they progress through lactation, and overall herd life.   
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ABSTRACT 
Bovine  clinical  mastitis  (CM)  can  be  detrimental  to  a  dairy  farm’s 
profitability, not only in terms of lost production and treatment costs, but also because 
of  the  loss  of  the  cows  themselves.  Our  objective  was  to  estimate  the  effects  of 
multiple  occurrences  of  generic  bovine  CM  on  mortality  and  culling.  We  studied 
16,145  lactations  from  5  large,  high  producing  dairy  herds,  with  3,036  first,  758 
second,  and  288  third  CM  cases  observed  in  the  first  10  months  after  calving. 
Generalized mixed models, with a random herd effect, were used to quantify the effect 
of CM on mortality and culling. Other control variables included in the models were 
parity, stage of lactation, and other diseases. CM in the current month significantly 
increased mortality in all parities. Among primipara, odds ratios and 95% confidence 
intervals were 5.6 (1.7, 18.0), 23.3 (7.1, 76.2), and 27.8 (3.7, 209.9)  for the  first, 
second, and third CM episode respectively. Among multipara, respective estimates 
were 9.9 (7.4, 13.2), 12.0 (8.0, 18.0), and 11.5 (6.1, 21.4). CM significantly increased 
the risk of a cow to be (voluntarily) culled for a period of at least 2 months after any 
CM case.  Our findings provide dairy producers with information on mortality and 
culling associated with CM cases without considering the causative agent, and can 
also be used for economic analysis of CM treatment options. 
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INTRODUCTION 
Mastitis  is  a  very  common  disease  in  dairy  herds  throughout  the  world  (e.  g. 
Barkema et al., 1998; Rajala Schultz et al., 1999; Sviland and Waage, 2002). The 
occurrence  of  mastitis  can  be  detrimental  to  a  dairy  farm’s  profitability,  not  only 
because  of  lost  production  and  increased  treatment  costs,  but  also  because  of 
decreased survival of the cow (Seegers et al., 2003). Clinical mastitis (CM) can be 
caused by many different pathogens, differing in their effects (Gröhn et al., 2004; 
Gröhn et al., 2005). However, the current situation on most farms, and for most cases, 
is  that  because  CM  milk  is  not  cultured  before  treatment,  farmers  have  to  make 
treatment, culling  and prevention decisions without knowledge of the specific CM 
causing agent. 
Studies have shown the increased risk of a cow contracting CM being culled from 
the  herd  (Gröhn  et  al.,  1998;  Neerhof  et  al.,  2000).  However,  for  any  economic 
analysis, there is a need to separate involuntary culling (i.e. independent from the 
farmer’s decision process), i.e. mortality, from an active decision of a farmer to sell 
the cow (i.e. culling). This distinction is essential because the economic outcome is 
different for a cow that dies on the farm and for a cow that was sold and generates 
sales  revenue.  In  addition,  in  economic  models  that  involve  replacement  policy 
optimization, it is necessary to separate events that are forced on the dairy farmer with 
some probability, from an active culling decision determined by model calculations. 
Although CM is often a recurring event (e.g. Houben et al., 1993; Döpfer et al., 
1999; Zadoks et al., 2001), the effect of only the first case of CM on culling was 
previously  estimated  (Gröhn  et  al.,  2005),  because  not  enough  observations  were 
available to address repeated CM cases also. It is plausible to expect that repeated 
cases of CM will have a different impact on mortality and culling decisions than that  
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determined by modeling only the first CM cases. A further motivation for the current 
study arose from an objective to later incorporate the effects of CM into an economic 
optimization  and  simulation  model  (using  Markov  process  techniques).  In  these 
replacement optimization models, the herd life of a dairy cow is described through 
transition probabilities.  
Recent studies (e.g. Neerhof et al., 2000; De Vliegher et al., 2005; Gröhn et al., 
2005) on the effect of CM on culling used the semi parametric Cox model, so that 
only the increased culling hazards were modeled, without calculating actual risks. An 
alternative approach to the semi parametric Cox model is to represent the survival 
time as a set of discrete time observations and indicators of whether or not an event 
occurred in each time unit (until the cow either experiences the event or is censored), 
thereby assuming a constant hazard during each unit of time. In each time unit the 
covariates  are  allowed  to  change  (Allison,  1995).  As  a  result,  the  dichotomous 
approach  is  more  useful  for  inclusion  of  time dependent  covariates  and  the 
proportional hazards assumption is relaxed (Hedeker et al., 2000). The estimates from 
these models can be expressed directly as probabilities. As in the case of discrete data 
the  mean  and  variance  are  related  (and  often  estimated  using  a  single  parameter). 
Correct statistical treatment of discrete correlated data is of importance, not only for 
variance estimation, but also for estimation of the mean (Schukken et al., 2003). Since 
these  are  essentially  Generalized  Linear  Models,  commercial  software  is  readily 
available to incorporate multi level random effects into these models (SAS, 2006). 
Our objective in this paper was to estimate the effects of multiple occurrences of 
CM (within lactations) on mortality and culling using generalized linear mixed model 
analysis.  
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MATERIALS AND METHODS 
Herd Description 
We used data from 5 dairy farms, located in New York State. These farms milked 
an average of 1,200, 1,100, 750, 650 and 600 Holstein milking cows respectively and 
were followed for approximately 24 months. The rolling herd average was close to 
11,000 kg per cow/yr on a 305 d basis (range 10,700 to 11,500); monthly mean SCC 
was 225,000 cells/mL (monthly range, 180,000 to 355,000), and varied relatively little 
among the 5 farms. Cows were housed in covered barns with concrete floors and free 
stalls and were classified by lactation, production, and reproductive status into feeding 
groups. All groups of cows were fed a balanced total mixed ration via feed alleys with 
headlocks that allowed restraint of cows for examination and treatments. Cows were 
milked 3 times per day. Each milking unit had milk meters capable of automatically 
recording milk production and (in 2 farms) milk conductivity. Farm personnel used 
DairyComp305
®  herd  management  software  (Valley  Agricultural  Software,  Tulare, 
California) to record lactation, reproductive, and medical data for each cow. Reliable 
data (because they were used by the herd personnel to manage the dairy) were readily 
available on parity, diseases, drying off, calving, and exit from the herd. Cows that 
were found dead or had been euthanized because their expected beef price was less 
than  the  transportation  costs,  or  might  have  drug  residues  because  of  a  medical 
treatment, were noted by the herd personnel as “Dead” with a remark containing the 
(often assumed) cause. Culled cows were noted as “Sold” (to a beef handler) with a 
remark for the culling reason. As the decision to cull a cow is often a mixture of 
reasons, and examination of the data showed often discrepancies between the noted 
culling reason and the cow traits (e.g. low production as the culling reason for an open 
cow 450 days after calving), we decided to disregard this information for our analysis 
and treat culling as a generic event.  
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Case definition 
  All lactating cows in the 5 study herds were eligible for inclusion in the study.  
All  milkers  on  the  cooperating  farms  were  familiar  with  detection  of  CM  by 
examination of foremilk. Most cases of CM were identified by milkers (warm, swollen 
udder  or  changes  in  the  milk),  while  others  were  detected  by  the  herdsperson 
examining  cows  whose  milk  electrical  conductivity  had  increased  and  had  a 
concurrent drop in milk production. Sick cows were treated according to well defined 
protocols that were similar but not completely the same (e.g. the exact supportive 
treatment given to cows) in all 5 farms, and throughout the study (e.g. one farm treated 
also Gram negative CM cases with antibiotics at the first months of the study). Farm 
personnel sampled milk for microbiological culture from quarters with signs of CM. 
The  samples  were  usually  collected  daily  and  were  cultured  by  the  Quality  Milk 
Production Services laboratories. The bacteriological culture procedures are described 
in detail in Gröhn et al. (2004).  
Some cows had 2 clinical episodes in the same quarter within several days of each 
other. Any such episode that occurred within 5 d (with either the same or a different 
etiologic  agent  isolated),  or  occurred  within  14  d  with  the  same  etiologic  agent 
isolated from both occurrences, was considered the same case of mastitis. Any episode 
that occurred more than 14 d after the previous episode was considered a new CM 
case (Barkema et al., 1998).   
Other Diseases 
While focusing on CM, we also chose 5 other diseases for inclusion in the models 
as  potential  confounders.  These  5  diseases  are  among  the  most  common  clinical 
conditions that are universally a problem in dairy cows. Reliable information about 
their occurrence was present in the dataset for all farms. The rationale for including 
these diseases in the analysis is that they may be associated with mastitis and also  
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affect herd life. 
The 5 recorded diseases (in addition to CM) were milk fever, retained placenta, 
metritis, ketosis, and displaced abomasum (DA). They were defined as follows: a) 
milk fever occurred if a cow was unable to rise or had cool extremities and sluggish 
rumen motility near the time of calving, but was treated successfully with calcium; b) 
retained placenta was retention of fetal membranes for at least 24 hrs post calving; c) 
metritis involved a febrile state accompanying a purulent or fetid vaginal discharge, or 
a diagnosis of an enlarged uterus by veterinary palpation; d) ketosis was diagnosed by 
detection of ketones in milk or urine, and response to treatment; e) DA occurred when 
the abomasum was enlarged with fluid, gas, or both, and was mechanically trapped in 
either the left or right side of the abdominal cavity. Every effort was taken to ensure 
that disease definition and diagnostic criteria were consistent across herds. Written 
disease definitions were provided to the dairy producers and veterinarians involved. 
 
Statistical Methods 
The  SAS
®  procedure  PROC  GLIMMIX  (SAS  Institute,  Inc.,  Cary,  NC,  USA, 
release June 2006) was used to study the effects of CM and several control variables 
(herd, parity, stage in lactation) on the odds of mortality of a cow, or the odds of being 
culled.  Because we were not interested in an individual farm but rather farms in 
general with these characteristics (i.e. large, high milk producing dairy farms with low 
incidence of contagious mastitis), and we expected a correlation between cows in a 
given herd, herd was modeled as a random (intercept) effect. The other covariates 
were modeled as fixed effects. 
Primipara and multipara were analyzed separately, because of the differing risks 
of outcome, and a potentially different CM effect. The first 2 months of the lactation 
were analyzed separately from the latter part of the (standard 305 days) lactation, as  
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otherwise a complex interaction term between the CM index (see below) and the stage 
in lactation was necessary. Because only a few cows had more than one CM in the 
first 2 months of the lactation, only the first case of CM was considered in the analysis 
of this time period. The model for this time period also included calving diseases as 
confounders. For the latter part of the lactation the first 3 cases of CM were analyzed. 
Higher order CM occurrences were not considered in the analysis because of the low 
numbers of observations on 4 or more CM occurrences. A p value below 0.05 was 
considered significant for drawing inferences.  
The generalized mixed model generalizes the standard model as follows:  
              g(Y)= X β + Z γ + ε 
where g is a link function, Y is the vector of observations, β is an unknown vector of 
fixed effect  parameters  with  known  design  matrix X, γ  is  an  unknown  vector  of 
random effect parameters with known design matrix Z, and ε is an unknown random 
error  vector  whose  elements  are  no  longer  required  to  be  independent  and 
homogeneous. γ and ε are Gaussian random variables that are uncorrelated and have 
expectations 0 and variances  G and R, respectively. The variance of  g(y) is: V = 
ZGZ’+R (when R=σ
2I and Z=0, the generalized mixed model reduces to the standard 
generalized model).  
The link function in our study was the natural log of the odds of a cow dying or 
being sold in a month. Fixed effects in our models were (for multiparous cows): parity 
with 3 levels (2
nd, 3
rd, and 4
th and higher lactation number); stage in lactation with 2 
levels (1
st and 2
nd month, and 3 5 and 6 10 months for the 2 time periods analyzed); 
and CM index, which is detailed below. For the first time period after calving we 
included  in  the  X  matrix  5  additional  binary  covariates  (for  milk  fever,  retained  
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placenta, metritis, ketosis, and DA). The random effect was herd modeled as a random 
intercept (G matrix). For Parity 1 cows, the same model was used, except that the 
terms containing parity and milk fever were omitted, as they were not applicable. We 
chose the time step of one month because of convergence problems using weekly or 
daily time periods and because the economic model we intend to use has a monthly 
time step. 
The CM coding schemes were determined after preliminary analysis of the dataset, 
and are illustrated in Table 3.1. For mortality analysis, the CM index had 4 levels 
(values of levels are in parentheses): 1
st CM occurring in the current month of the 
lactation (1), 2
nd CM case (in the current lactation) occurring in the current month of 
the lactation (2), 3
rd CM case occurring in the current month of the lactation (3), and 
free of CM in that month (10). For culling analysis, another CM index with 10 levels 
(values of levels are in parentheses) was used: 1
st CM occurring in the current month 
of the lactation (1), 1
st CM occurring in the previous month (2), 1
st CM occurring 2 
and more months ago (3), 2
nd CM case in the current month of lactation (4), 2
nd CM 
occurring in the previous month (5), …, 3
rd CM case occurring 2 and more months ago 
(9), and free of CM until that month (10). If 2 CM codes were relevant for the same 
time period (e.g. 2 CM cases in the same month), the code given was according to the 
last event. Cow 1030 in Table 3.1 is an example of how such conflicts were treated.   
  41 
 
Table 3.1. Data for 4 example cows illustrating the parameterization schemes used in 
the statistical analysis of this study. 
 
Cow 
id 
Month 
in milk 
Month 
of 1
st 
CM
1 
case 
Month 
of 2
nd 
CM 
case 
Month 
of 3
rd 
CM 
case 
CM Index 
variable 
for 
mortality 
CM 
Index 
variable 
for 
culling 
Died  Sold 
1006  1  3  7  10  10  10  0  0 
1006  2  3  7  10  10  10  0  0 
1006  3  3  7  10  1  1  0  0 
1006  4  3  7  10  10  2  0  0 
1006  5  3  7  10  10  3  0  0 
1006  6  3  7  10  10  3  0  0 
1006  7  3  7  10  2  4  0  0 
1006  8  3  7  10  10  5  0  0 
1006  9  3  7  10  10  6  0  0 
1006  10  3  7  10  3  7  0  0 
1012  1  .  .  .  10  10  0  0 
1012  2  .  .  .  10  10  0  0 
1012  3  .  .  .  10  10  0  0 
1012  4  .  .  .  10  10  1  0 
1025  1  2  .  .  10  10  0  0 
1025  2  2  .  .  1  1  0  1 
1030  1  1  3  3  1  1  0  0 
1030  2  1  3  3  10  2  0  0 
1030  3  1  3  3  3  7  0  0 
1030  4  1  3  3  10  8  0  0 
1030  5  1  3  3  10  9  0  1 
1 CM = clinical mastitis 
 
 
 
RESULTS 
Descriptive Findings 
Our dataset contained data on 16,145 lactations from the 5 herds. In the first 10 
months of the lactation, 3,036 cows had experienced their first CM case, 758 cows 
their second CM case, and 288 cows their third CM case. In the first 10 months after 
calving, 960 cows died and 1,995 cows were sold (for any reason). The probability of  
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a cow dying or being sold is graphically presented for primiparous cows in Figure 3.1 
and multiparous cows in Figure 3.2. 
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Figure 3.1. Probability of a cow dying (dotted pattern) or being voluntarily culled 
(vertical lines) in 5,500 first lactations in 5 NY State dairy herds. 
 
Although we did not model the mastitis causing pathogens separately in this study, 
the bacteriological results of the samples taken at the time of CM are presented in 
Table 3.2.  In the vast majority of the CM cases no contagious pathogen was isolated; 
therefore our initial definition of these 5 farms as having effective control programs 
against  contagious  mastitis  was  confirmed.  The  median  day  of  lactation  of  the 
occurrence of the first CM episode was similar in both primipara (91) and multipara 
(90).  In  contrast,  subsequent  CM  episodes  occurred  sooner  in  multipara  than  in 
primipara.  
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Figure 3.2. Probability of a cow dying (dotted pattern) or being voluntarily culled 
(vertical lines), in 10,645 multiparous lactations in 5 NY State dairy herds. 
 
 
Table 3.2. Pathogens isolated from milk of the first, second and third case of clinical 
mastitis (CM) in 16,145 lactations in 5 NY State dairy herds. 
      Primipara        Multipara   
    1
st CM  2
nd CM  3
rd CM    1
st CM  2
nd CM  3
rd CM 
Cases    644  100  26    2393  658  262 
Median day
1    91  184  192    90  140  168 
E. coli    24%  28%  31%    29%  23%  17% 
Klebsiella    6%  10%  12%    10%  12%  19% 
No Growth
2  11%  13%  19%    18%  17%  21% 
Strep. spp.  23%  20%  0%    18%  19%  18% 
Staph. aureus  7%  3%  4%    4%  5%  6% 
CNS    6%  1%  12%    4%  2%  2% 
A. pyogenes  2%  5%  8%    1%  2%  2% 
Yeast    3%  4%  0%    3%  1%  1% 
Other
3    5%  6%  8%    2%  5%  4% 
Undefined
4    13%  10%  8%    9%  10%  10% 
1median day of lactation of CM occurrence;
 2 fewer than 2 colonies per plate; 
3 any 
organism not specified above 
4 more than 3 different organisms isolated (i.e. contaminated 
sample) 
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As we were interested specifically in repeated occurrences of CM, the number of 
real  repeated  cases  caused  by  the  same  pathogen  (detailed  data  not  shown)  is  of 
interest. Among primipara, in 42% of the second CM cases, the same pathogen as in 
the  first  CM  case  was  isolated;  among  multipara,  the  corresponding  recurrence 
probability  was  36%.  Among  primipara,  in  50%  of  the  third  CM  cases,  the  same 
pathogen  as  in  the  first  or  second  CM  case  was  isolated;  among  multipara  the 
corresponding proportion was 48%. Therefore, slightly less than half of the repeated 
cases were caused by the same pathogen.  
 
The effects of the first CM case on mortality and voluntary culling at the beginning 
of the lactation 
Parameter estimates from the models for the first 2 months of the lactation are 
presented in Table 3.3. CM in the current month significantly increased mortality both 
in  primipara  (odds  ratio  (OR):  exp(1.41)=4.1)  and  multipara  (OR=2.3).  CM 
significantly increased the risk of a multiparous cow being culled for a period of 2 
months after diagnosis (OR=3.4 and 2.9 for the same and following month after CM 
respectively).  
 
The effects of the first three CM cases on mortality 
Parameter estimates from the models for months 3 to 10 of the lactation are 
presented in Table 3.4. CM in the current month significantly increased mortality. The 
odds of primiparous cows, in the month CM was diagnosed, dying were 5.6, 23.3, and 
27.8 times higher for the first, second, and third CM episode respectively, compared to 
a CM free cow in that month. Among multipara, respective estimates were 9.9, 12.0, 
and 11.5 for the first, second, and third CM case respectively.  
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Table 3.3. Effects of the first clinical mastitis (CM) case on mortality and culling in 
16,145 lactations in 5 New York State dairy farms over the first 2 months of the 
lactation; estimates were obtained from generalized mixed models with a random herd 
effect   
  Primiparous cows  Multiparous cows 
  Died  Sold  Died  Sold 
Parameter  Estimate  (SE
2)  Estimate  (SE)  Estimate  (SE)  Estimate  (SE) 
Intercept
1   5.30***  (0.27)   4.73***  (0.21)   4.32***  (0.29)   3.45***  (0.17) 
                 
1
st CM 1 30d   1.41***  (0.32)   0.61  (0.52)   0.83***  (0.17)   1.23***  (0.16) 
                 
1
st CM >31d       0.20  (0.73)      1.04***  (0.25) 
                 
Parity 2           1.27***  (0.14)   1.59***  (0.14) 
                 
Parity 3           0.38***  (0.11)   0.67***  (0.12) 
                 
1
st month   1.01  (0.22)   0.04  (0.21)   0.93***  (0.12)   0.24**  (0.11) 
                 
Milk Fever           1.80***  (0.15)   0.13  (0.29) 
                 
Ret. Placenta   0.66*  (0.33)   0.11  (0.53)   0.61***  (0.14)   0.49*  (0.22) 
                 
Metritis   0.53  (0.47)   0.45  (0.61)   0.3  (0.22)   0.08  (0.29) 
                 
Ketosis   0.14  (0.35)   0.23  (0.35)   0.59***  (0.15)   0.10  (0.17) 
                 
DA   1.13***  (0.33)   1.11**  (0.37)   0.74***  (0.17)   0.98***  (0.17) 
1 In primiparous cows, log of the odds of a cow in the second month of the lactation, 
free of CM and calving diseases. In multiparous cows, log of the odds of a cow in the 
4
th and higher lactation, in the second month of the lactation, and free of CM and 
calving diseases; 
2SE = standard error 
*p<0.05; **p<0.01; ***p<0.001 
 
The effects of the first three CM cases on voluntary culling 
Parameter estimates from the models for months 3 to 10 of the lactation are 
presented in Table 3.4. CM significantly increased the risk of a cow being culled in all 
parities for a period of at least 2 months after diagnosis. After the 3
rd CM case, the 
odds of culling the cow were, even 2 months after CM had occurred, more than 4 
times as high as the odds of a cow without CM. 
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Table 3.4. Effects of the first 3 clinical mastitis (CM) cases on mortality and culling 
in 14,323 lactations in 5 New York State dairy farms over months 3 to 10 of the 
lactation; estimates were obtained from generalized mixed models 
  Primiparous cows  Multiparous cows 
  Died  Sold  Died  Sold 
Parameter  Estimate  (SE
2)  Estimate  (SE)  Estimate  (SE)  Estimate  (SE) 
Intercept
1   6.56***  (0.18)   5.47***  (0.11)   5.47***  (0.17)   3.52***  0.13) 
                 
1
st CM 1 30d  1.72***  (0.60)  2.01***  (0.31)  2.29***  (0.15)  1.32***  (0.11) 
                 
1
st CM 31 60d      1.95***  (0.33)      1.44***  (0.12) 
                 
1
st CM >60d      0.34  (0.30)      0.43***  (0.10) 
                 
2
nd CM 1 30d  3.15***  (0.60)  2.78***  (0.43)  2.48***  (0.21)  1.61***  (0.16) 
                 
2
nd CM 31 60d      3.48***  (0.39)      1.46***  (0.19) 
                 
2
nd CM  >60      0.38  (1.01)      0.17  (0.23) 
                 
3
rd CM 1 30d  3.33***  (1.03)  3.00***  (0.74)  2.44***  (0.32)  1.85***  (0.21) 
                 
3
rd CM 31 60d      2.44*  (1.03)      2.05***  (0.22) 
                 
3
rd CM >60d      2.78***  (0.61)      1.42***  (0.19) 
                 
Parity 2           0.53***  (0.14)   0.95***  (0.07) 
                 
Parity 3           0.14  (0.14)   0.39***  (0.07) 
                 
Months 3 5  0.05  (0.27)  0.13  (0.15)  0.35**  (0.11)   0.23***  (0.06) 
1 In primiparous cows, log of the odds of a cow in months 6 10 of the lactation, and 
free of CM. In multiparous cows, log of the odds of a cow in the 4
th and higher 
lactation, in months 6 10 of the lactation and CM free; 
2SE = standard error 
*p<0.05; **p<0.01; ***p<0.001 
 
 
The effects of the first three CM cases on productive life 
CM increased both mortality as well as the risk of a cow being culled. The 
statistical models results presented in Tables 3.3 and 3.4 can be expressed easily in 
probability  terms  by  exponentiation  the  parameter  estimates  and  transforming  the 
resulting odds into probabilities. As an example, the probability of cows in their first 
lactation, 6 10 month after calving’ with the 1
st CM case occurring in  the current 
month, to die is exp( 6.56+1.72)/(1+exp( 6.56+1.72))=0.0078. In Figure 3.3 the effect 
of either the 1
st, 2
nd, or 3
rd CM case occurring in the current month, on the probability  
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of cows in their first (A), second (B), third (C), or fourth and higher (D) lactation, 6 10 
months after calving, leaving the herd in this given month is graphically presented. 
Recurrent CM cases are of increasing detrimental effect on herd life. 
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Fig 3.3. Probability of cows in their first (A), second (B), third (C), or fourth and 
higher (D) lactation, 6 10 months after calving, dying (dotted pattern) or being 
voluntarily culled (vertical lines) per month, if they were free of CM, or had their first, 
second, or third CM case in that month. 
 
 
 
DISCUSSION 
Our objective was to analyze the decreased survival of cows after CM in 2 
separate  components:  (1)  the  decreased  survival  outside  the  decision  process  of  a 
farmer, i.e. mortality, or involuntary culling (including euthanized cows), and (2) the 
voluntary decision to sell a cow for slaughter (voluntary culling). CM increased the  
  48 
odds of a cow dying, regardless of the CM case number. CM also increased the odds 
of a cow being sold for slaughter. The increased risk of being sold was apparent for a 
period of at least 2 months after CM and lasted for a long time if it was the third case 
in this lactation. 
The overall mortality risk observed in our study is a little higher than estimated 
by  Esslemont  and  Kossaibati  (1997),  but  in  line  with  findings  in  all  DHIA  data 
recovered from the same area as where these herds are located (Hadley et al., 2006). In 
that study no CM records were available, but high SCC was still an important cause 
for early culling. The farmers in our study reported that about half of the dead cows 
were actually euthanized, similar to the estimate made by Thomsen et al. (2004). Long 
drug  withdrawal  periods,  combined  with  high  transportation  costs  to  the 
slaughterhouse, often make this decision the most economical one. Nevertheless, such 
an outcome is still considered to be outside the decision process of a farmer and incurs 
only costs. On the other hand, the increased risk of cows being sold for slaughter after 
CM is due, at least partly, to an active comparison of the farmer’s options to sell the 
cow and to replace her with a new animal, or to treat the cow and keep her in the herd 
for at least another month.  
Although not often, 2 CM cases were sometimes present in the same month, or 
a short time thereafter. The CM coding scheme we used in our analysis assigned all 
effects from previous CM cases to the last event in the same month. Since the cows 
were obviously not culled after the earlier events in the same month, this appears to be 
the more logical choice.  
In  all  models,  death  related  to  CM  remained  the  same  or  increased  with 
increasing case number. In a previous paper (Chapter 2), we also observed in the same 
data that milk loss with each subsequent case of mastitis was approximately the same, 
particularly when accounting for production level at the time of occurrence. These  
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findings  would  suggest  that  subsequent  cases  of  mastitis  present  with  a  similar 
severity  compared  to  the  first  case  of  a  cow  in  a  given  lactation.  Even  though 
approximately half of subsequent cases are caused by the same organism, no apparent 
benefits (in terms of limited milk production loss or increased survival) are obtained 
from a previous case. This would agree with previous studies where a very limited 
duration of presence of immunological memory or protection was observed after either 
vaccination (Burton and Erskine, 2003) or a full challenge (Lehtolainen et al., 2003). 
Vaccination studies often report a benefit of vaccination, but this benefit may be of 
relatively short duration as suggested by Burton and Erskine (2003), or from our data, 
where a full inflammatory response offers little benefit for future infections with the 
same organism. 
Risk of death and culling was almost always higher in first lactation animals 
versus second and older lactation animals given the same case number of mastitis. 
Mastitis challenge studies show consistently that heifers respond less severely to the 
same challenge (Vangroenweghe et al., 2004). However, our data indicated that under 
field conditions, mastitis was apparently equally or more severe in heifers versus older 
cows. This is an important finding, as heifers are generally less targeted for mastitis 
control programs (De Vliegher et al., 2004). 
CM can be caused by different pathogens, differing in their effects on milk 
yield (Gröhn et al., 2004) and on herd life (Gröhn et al., 2005). We treated CM as a 
generic entity because on most farms, and for most cases, CM milk is not cultured, 
and  the  farmers  have  to  make  treatment,  culling  and  prevention  decisions  without 
knowledge of the specific CM causing agent. To better understand the  biology of 
pathogen specific  mastitis,  it  would  be  essential  to  model  pathogen  specific  CM, 
especially when addressing repeated cases. The authors are well aware of this point, 
but a larger number of observation is needed to be able to address pathogen specific  
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repeated CM; the current number of lactations in our study is not sufficient. We hope 
to fill this gap in the near future.  
The estimates of this study can be directly incorporated into an appropriate 
economic model, as they can be expressed in actual monthly risks. The monthly time 
step of this analysis is in accordance with a replacement optimization and simulation 
model that we intend to construct and use for the estimation of the economic impact of 
CM. 
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ABSTRACT 
The objective of this study was to estimate the risk of recurrent generic clinical 
mastitis (CM) within and across lactations in dairy cows. We studied 13,513 lactations 
from 5 large, high producing dairy herds, with 2,879 first, 659 second, and 254 third 
CM  cases.  Generalized  mixed  models,  with  a  random  herd  effect,  were  used  to 
estimate the conditional risks for the first 3 CM occurrences. Risk of CM increased 
with higher parities. The risk of the first CM case was high in the first month after 
calving and fairly constant afterwards. The risks of the second and third CM cases 
were higher than the risk of the first CM case, and were higher in the first 2 months 
after the previous CM case. Cows that had one or more CM episodes in their previous 
lactation had a very high risk of suffering again a CM episode in the current lactation. 
Our findings provide dairy producers with information on the repeatability of generic 
CM cases and can also be used for economic analysis of CM treatment options.  
 
Keywords: clinical mastitis, risk, repeatability, generalized mixed model 
 
INTRODUCTION 
Mastitis is the most prevalent production disease in dairy herds worldwide and is 
responsible for production losses. Milk yield is severely affected (Wilson et al., 2004), 
and cows’ survival in the herd decreases (Gröhn et al., 1998). The associated rise in 
individual cow somatic cell count can lead to a rise in bulk tank somatic cell count and 
may result in a lower milk price (Seegers et al., 2003). All these factors make bovine 
mastitis  the  most  economically  important  disease  of  dairy  cattle.  Despite  effective 
control  programs  for  subclinical  mastitis,  clinical  mastitis  (CM)  remains  a  major 
economic burden in dairy farms (e.g. Makovec and Ruegg, 2003; LeBlanc et al. 2006). 
CM can be caused by many different pathogens, differing in their effects (Gröhn et al.,  
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2004; Gröhn et al., 2005). However, the current situation on most farms, and for most 
cases, is that because CM milk is not cultured before treatment, farmers have to make 
treatment, culling  and prevention decisions without knowledge of the specific CM 
causing agent.  
Although CM is often a recurring event (e.g. Houben et al., 1993; Döpfer et al., 
1999; Zadoks et al., 2001), estimations about repeatability of CM are scarce, mainly 
because a very large dataset is needed. It is plausible to expect that risks of repeated 
cases of CM will be different than that determined for the first CM case. A further 
motivation for the current study arose from an objective to later incorporate risk of 
CM  into  an  economic  optimization  and  simulation  model  (using  Markov  process 
techniques). In these replacement optimization models, the herd life of a dairy cow is 
described through (monthly) transition probabilities.  
An alternative approach to the popular semi parametric Cox model (which does 
not provide actual risks) is to represent the survival time as a set of discrete time 
observations and indicators of whether or not an event occurred in each time unit 
(until the cow either experiences CM or is censored), thereby assuming a flat hazard 
during  each  unit  of  time.  In  each  time  unit  the  covariates  are  allowed  to  change 
(Allison, 1995). As a result, the dichotomous approach is more useful for inclusion of 
time dependent  covariates  and  the  proportional  hazards  assumption  is  relaxed 
(Hedeker et al., 2000). The estimates from these models can be expressed directly as 
probabilities. As in the case of discrete data the mean and variance are related (and 
often  estimated  using  a  single  parameter).  Correct  statistical  treatment  of  discrete 
correlated  data  is  of  importance,  not  only  for  variance  estimation,  but  also  for 
estimation of the mean (Schukken et al., 2003). Since these are essentially Generalized 
Linear Models, commercial software is readily  available to incorporate multi level  
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random effects into these models (SAS, 2006). 
Our objective in this paper was to estimate the risk of multiple occurrences of CM 
within and across lactations, using generalized linear mixed model analysis.  
 
MATERIALS AND METHODS 
Herd Description 
We used data from 5 dairy farms, located in New York State. These farms milked 
an average of 1,200, 1,100, 750, 650 and 600 Holstein milking cows respectively and 
were followed for approximately 24 months. The rolling herd average was close to 
11,000 kg per cow/yr on a 305 d basis (range 10,700 to 11,500); monthly mean SCC 
was 225,000 cells/mL (monthly range, 180,000 to 355,000), and varied relatively little 
among the 5 farms. Cows were housed in covered barns with concrete floors and free 
stalls and were classified by lactation, production, and reproductive status into feeding 
groups. All groups of cows were fed a balanced total mixed ration via feed alleys with 
headlocks that allowed restraint of cows for examination and treatments. Cows were 
milked  3  times  per  day.  Farm  personnel  used  DairyComp305®  herd  management 
software  (Valley  Agricultural  Software,  Tulare,  California)  to  record  lactation, 
reproductive, and medical data for each cow. Reliable data (because they were used by 
the  herd  personnel  to  manage  the  dairy)  were  readily  available  on  parity,  CM, 
laboratory results, drying off, calving, and exit from the herd.  
Case definition 
  All lactating cows in the 5 study herds that were observed for at least 6 months 
before the last calving date were eligible for inclusion in the study.  Most cases of CM 
were identified by milkers (warm, swollen udder or changes in the milk), while others  
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were  detected  by  the  herdsperson  examining  cows’  performance.  Sick  cows  were 
treated  according  to  well defined  protocols.  Farm  personnel  sampled  milk  for 
microbiological culture from quarters with signs of CM. The samples were usually 
collected  daily  and  were  cultured  by  the  Quality  Milk  Production  Services 
laboratories. The bacteriological culture procedures are described in detail in Gröhn et 
al. (2004).  
Some cows had 2 clinical episodes in the same quarter within several days of each 
other. Any such episode that occurred within 5 d (with either the same or a different 
etiologic  agent  isolated),  or  occurred  within  14  d  with  the  same  etiologic  agent 
isolated from both occurrences, was considered the same case of mastitis. Any episode 
that occurred more than 14 d after the previous episode was considered a new CM 
case (Barkema et al., 1998).   
Statistical Methods 
The  SAS®  procedure  PROC  GLIMMIX  (SAS  Institute,  Inc.,  Cary,  NC,  USA, 
release June 2006) was used to study the risk of CM as a function of several covariates 
(herd, parity, months after calving or last CM).  Because we were not interested in an 
individual farm but rather farms in general with these characteristics (i.e. large, high 
milk  producing  dairy  farms  with  low  incidence  of  contagious  mastitis),  and  we 
expected a correlation between cows in a given herd, herd was modeled as a random 
(intercept) effect. The other covariates were modeled as fixed effects. 
Primipara  and  multipara  were  analyzed  separately,  because  of  possible  effect 
modifications. The analysis was run for each CM occurrence; i.e. in the analysis of the 
risk for the second CM case, only cows that had experienced a first CM case were 
included, and only data after the first case were included. Only the first 3 cases of CM 
per lactation were analyzed. Higher order CM occurrences were not considered in the  
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analysis because of the low numbers of observations on 4 or more CM occurrences. A 
p value below 0.05 was considered significant for drawing inferences.  
The generalized mixed model we used generalizes the standard generalized model 
as follows:  
              g(Y)= X β + Z γ + ε 
where g is a link function, Y is the vector of observations, β is an unknown vector 
of fixed effect parameters with known design matrix X, γ is an unknown vector of 
random effect parameters with known design matrix Z, and ε is an unknown random 
error  vector  whose  elements  are  no  longer  required  to  be  independent  and 
homogeneous. γ and ε are Gaussian random variables that are uncorrelated and have 
expectations  0  and  variances  G  and  R,  respectively.  The  variance  of  g(y)  is:  V  = 
ZGZ’+R (when R=σ
2I and Z=0, the generalized mixed model reduces to the standard 
generalized model).  
The link function in our study was the natural log of the odds of a cow having CM 
in the current month. Fixed effects (X matrix) in our models were (for multiparous 
cows): parity with 3 levels (2
nd, 3
rd, and 4
th and higher lactation number); time (either 
after calving for the first case or after previous CM for repeated cases) with 4 levels 
(1
st  month,  2
nd  month,  3
rd  month,  4
th  month  and  later);  and  a  binary  covariate, 
indicating if the cow had had at least one CM case in her previous lactation or not. The 
random effect (Z matrix) was herd modeled as a random intercept. For Parity 1 cows, 
the same model was used, except that parity and carry over terms were omitted, as 
they  were  not  applicable.  We  chose  the  time  step  of  one  month  because  of 
convergence problems using weekly or daily time periods and because the economic 
model we intend to use has a monthly time step.  
  60 
RESULTS 
Descriptive Findings 
Our dataset contained data on 13,513 lactations from the 5 herds. In the first 10 
months of the lactation, 2,879 cows had experienced their first CM case, 659 cows 
their second CM case, and 234 cows their third CM case. 
Although we did not model the mastitis causing pathogens separately in this study, 
the bacteriological results of the samples taken at the time of CM are presented in 
Table 4.1.  In the vast majority of the CM cases no contagious pathogen was isolated; 
therefore our initial definition of these 5 farms as having effective control programs 
against contagious mastitis was justified.  
 
Table 4.1. Pathogens isolated from milk of the first, second and third case of clinical 
mastitis (CM) 
    Primipara    Multipara 
    1
st CM  2
nd CM  3
rd CM    1
st CM  2
nd CM  3
rd CM 
# of cases    621  84  21    2258  575  213 
Median day
1  82  181  195    87  135  168 
Escherichia coli  28%  24%  29%    28%  21%  18% 
Klebsiella    6%  7%  5%    13%  13%  18% 
No Growth
2  10%  14%  19%    19%  21%  25% 
Streptococcus spp.  18%  24%  14%    17%  19%  17% 
Staphylococcus aureus  5%  2%  5%    4%  5%  6% 
CNS    3%  2%  5%    2%  2%  2% 
A. pyogenes
3  2%  2%  5%    1%  2%  1% 
Yeast    5%  6%  0%    1%  1%  0% 
Other
4    6%  9%  4%    4%  4%  4% 
Undefined
5    17%  10%  14%    11%  12%  9% 
1 median day of lactation of CM occurrence;
 2 fewer than 2 colonies per plate; 
3 Arcanobacterium pyogenes;  
4 any organism not specified above 
5 more than 3 different organisms isolated (i.e. contaminated sample) 
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As we were interested specifically in repeated occurrences of CM, the number of 
repeated cases caused by the same pathogen (detailed data not shown) is of interest. 
Among primipara, in 42% of the second CM cases, the same pathogen as in the first 
CM case was isolated; among multipara, the corresponding recurrence probability was 
35%. Among primipara, in 57% of the third CM cases, the same pathogen as in the 
first or second CM case was isolated; among multipara the corresponding proportion 
was 51%. Therefore, fewer than half of second CM cases were caused by the same 
pathogen, but a slight majority of third CM cases were caused by the same pathogen 
as in a previous case(s).  
Risk of first CM case 
Results of the models for estimating the risk of the first CM case in the lactation 
are summarized in Table 4.2. Primiparous cows had a high risk of CM in the first 
month after calving, and a constant risk afterwards. Multiparous cows had a higher 
overall risk for the first CM case than primipara, and this risk increased with age. The 
risk for CM was higher in the first month after calving, and was slightly higher in the 
third month, compared to the risk in the latter part of the lactation. Cows that had one 
or more CM episodes in their previous lactation (there were 544 such cows) had a very 
high risk of suffering again a CM episode in the current lactation. This high carry over 
effect was consistent in all the farms (detailed results not shown).  
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Table 4.2. Monthly risk for the first clinical mastitis (CM) occurrence in the lactation 
in 13,513 lactations in 5 New York State dairy farms; estimates were obtained from 
generalized mixed models with a random herd effect 
  Primipara  Multipara 
  Estimate  OR
3  Estimate  OR 
Parameter  (SE
2)  (95% CI)  (SE)  (95% CI) 
Intercept
1   4.45***     3.33***   
  (0.26)    (0.14)   
         
1 30d
4  1.25***  3.5  0.45***  1.6 
  (0.09)  (2.9, 4.2)  (0.06)  (1.4, 1.7) 
         
31 61d  0.03  1.0   0.05  1.0 
  (0.14)  (0.8, 1.4)  (0.07)  (0.8, 1.1) 
         
62 92d   0.05  1.0  0.21**  1.2 
  (0.15)  (0.7, 1.3)  (0.07)  (1.1, 1.4) 
         
Parity 2
5       0.46***  0.6 
      (0.05)  (0.6, 0.7) 
         
Parity 3       0.16**  0.9 
      (0.06)  (0.8, 1.0) 
         
CM in previous lactation      2.39***  10.9 
      (0.06)  (9.7, 12.2) 
1 In primiparous cows, log of the odds of a cow in months 4 10 of the lactation. In 
multiparous cows, log of the odds of a cow in the 4
th and higher lactation, in months 4 
10 of the lactation and without CM in the previous lactation; 
2SE = standard error; 
3OR = odds ratio; 
4relative to >92 days after calving; 
5relative to parity 4 and above; 
*p<0.05; **p<0.01; ***p<0.001 
 
Risk of second CM case 
Results of the models for estimating the risk of the second CM case in the lactation 
are summarized in Table 4.3. Primiparous cows had a high risk of CM in the first 
month after the first CM case, and a constant risk afterwards. Multiparous cows had a 
higher overall risk for the second CM case than primipara, and this risk increased with 
age. The risk for CM was higher in the first 2 months after the first CM case compared 
to the risk in the latter part of the lactation. Cows that had one or more CM episodes in  
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their previous lactation (183 cows) had a higher risk of suffering 2 CM episodes in the 
current lactation.  
 
Table 4.3. Monthly risk for the second clinical mastitis (CM) occurrence in the 
lactation in 2,288 lactations of cows that had already experienced 1 case of CM in 5 
New York State dairy farms; estimates were obtained from generalized mixed models 
with a random herd effect 
  Primipara  Multipara 
  Estimate  OR
3  Estimate  OR 
Parameter  (SE
2)  (95% CI)  (SE)  (95% CI) 
Intercept
1   3.83***     2.88***   
  (0.32)    (0.14)   
         
1 30d
4  0.77**  2.2  0.88***  2.4 
  (0.26)  (1.3, 3.6)  (0.11)  (1.9, 3.0) 
         
31 61d   0.09  0.9  0.68***  2.0 
  (0.36)  (0.5, 1.8)  (0.16)  (1.5, 2.5) 
         
62 92d   0.07  0.9  0.11  1.1 
  (0.37)  (0.5, 1.9)  (0.16)  (0.8, 1.5) 
         
Parity 2
5       0.38***  0.7 
      (0.11)  (0.6, 0.8) 
         
Parity 3       0.18**  0.8 
      (0.11)  (0.7, 1.0) 
         
CM in previous lactation      0.37**  1.5 
      (0.10)  (1.2, 1.8) 
1 In primiparous cows, log of the odds of a cow 4 and more months after the first CM case. In 
multiparous cows, log of the odds of a cow in the 4
th and higher lactation, 4 and more months 
after the first CM case and without CM in the previous lactation; 
2SE = standard error; 
3OR = 
odds ratio; 
4relative to >92 days after first CM; 
5relative to parity 4 and above; 
*p<0.05; **p<0.01; ***p<0.001 
 
Risk of third CM case 
Results of the models for estimating the risk of the third CM case in the lactation 
are  summarized  in  Table  4.4.  Because  there  were  only  21  third  CM  cases  in 
primiparous cows, the higher risk of a third case shortly after the second case is not 
statistically significant. Multiparous cows had a higher overall risk for the third CM  
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case than primipara; but this risk did not increase for the higher parities. The risk for 
CM was higher in the first 2 months after the second CM case compared to the risk in 
the latter part of the lactation.  
 
Table 4.4. Monthly risk for the third clinical mastitis (CM) occurrence in the lactation 
in 586 lactations of cows that had already experienced 2 cases of CM in 5 New York 
State dairy farms; estimates were obtained from generalized mixed models with a 
random herd effect 
  Primipara  Multipara 
  Estimate  OR
3  Estimate  OR 
Parameter  (SE
2)  (95% CI)  (SE)  (95% CI) 
Intercept
1   3.58**     2.66***   
  (0.72)    (0.26)   
         
1 30d
4  1.2  3.3  0.71***  2.0 
  (0.62)  (1.0, 11.2)  (0.21)  (1.4, 3.0) 
         
31 61d  1.0  2.7  0.70**  2.0 
  (0.70)  (0.7, 10.8)  (0.22)  (1.3, 3.1) 
         
62 92d  0.34  1.4  0.11  1.1 
  (0.89)  (0.2, 8.1)  (0.28)  (0.6, 1.9) 
         
Parity 2
5      0.14  1.2 
      (0.19)  (0.8, 1.7) 
         
Parity 3      0.32  1.4 
      (0.18)  (1.0, 2.0) 
         
CM in previous lactation      0.23  1.3 
      (0.16)  (0.9, 1.7) 
1 In primiparous cows, log of the odds of a cow 4 and more months after the second CM case. 
In multiparous cows, log of the odds of a cow in the 4
th and higher lactation, 4 and more 
months after the second CM case and without CM in the previous lactation; 
2SE = standard 
error; 
3OR = odds ratio; 
5relative to >92 days after second CM; 
4relative to parity 4 and above; 
*p<0.05; **p<0.01; ***p<0.001  
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DISCUSSION 
The objective of this study was to estimate the risk of recurrent generic CM within 
and across lactations in dairy cows. Risk of CM increased with higher parities. The 
risk of the first CM case was high in the first month after calving and fairly constant 
afterwards. The risks of the second and third CM cases were higher than the risk of the 
first CM case; and were higher in the first 2 months after the previous CM case. Cows 
that had one or more CM episodes in their previous lactation had a very high risk of 
suffering again a CM episode in the current lactation. 
We treated CM as a generic entity because on most farms, and for most cases, CM 
milk is not cultured, and the farmers have to make treatment, culling and prevention 
decisions without knowledge of the specific CM causing agent. To better understand 
the biology of CM, it would be essential to model pathogen specific CM, especially 
when addressing repeated cases. The authors are well aware of this point, but a larger 
number of observations are needed to be able to address pathogen specific recurrent 
CM; the current number of lactations in our study is not sufficient. We hope to fill this 
gap in the near future.  
The  association  between  parity  and  the  risk  for  CM  is  well  documented  (e.g. 
Sviland and Waage, 2002); the same applies to the higher risk close to calving (e.g. 
Barkema, 1998). The association between the risk of CM and the time after a previous 
CM case is expected to be dependent on the etiological agent involved (Bradley and 
Green, 2001).  Despite the size of our dataset, such inferences were not possible to test 
in an efficient way. Therefore, our result should be treated as internally valid (i.e. for 
the study farm), without the intention of being externally valid. 
Even  though  approximately  half  of  subsequent  cases  are  caused  by  the  same  
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organism, no apparent benefits (in terms of risk of a subsequent CM case) are obtained 
from a previous case; the contrary is true. This would agree with previous studies 
where a very limited duration of presence of immunological memory or protection 
was observed after either vaccination (Burton and Erskine, 2003) or a full challenge 
(Lehtolainen et al., 2003). Vaccination studies often report a benefit of vaccination, 
but this benefit may be of relatively short duration as suggested by Burton and Erskine 
(2003),  or  from  our  data,  where  a  full  inflammatory  response  offers  no  apparent 
protection from future infections with the same organism. 
The  increased  risk  of  cows  suffering  a  recurrent  CM  case  either  in  the  same 
lactation or in the subsequent one is a result of several processes. The etiological agent 
can survive the immune system and flare up after some time (Bradley and Green, 
2001), and there seems to be a strong cow factor, especially with environmental CM 
causing agents (Döpfer et al., 1999). These cow factors can be temporary, such as 
chapped teat skin (Burmeister et al., 1998) and teat end callosity (Neijenhuis et al. 
2001), or permanent such as genetically driven risk factors (Schukken et al., 1999). 
Green et al. (2002) emphasized the dry period as being a crucial factor on the risk of 
CM in the subsequent lactation. Although our estimation of the risk of cows with CM 
in the previous lactation having CM in the current lactation seems too high, as it is 
even higher than the risk of repeated cases in the same lactation, these estimates are in 
accordance with the risks calculated by Green et al. (2002).  
The  estimates  of  this  study  can  be  directly  incorporated  into  an  appropriate 
economic model, as they can be expressed in actual monthly risks. The monthly time 
step of this analysis is in accordance with a replacement optimization and simulation 
model that we intend to use for the estimation of the economic impact of CM. 
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ABSTRACT 
The objective of this study was to estimate the cost of generic clinical mastitis 
(CM) in high yielding dairy cows given optimal decisions concerning handling of CM 
cases.  A  specially  structured  optimization  and  simulation  model  that  included  a 
detailed representation of repeated episodes of CM was used to study the effects of 
various factors on the cost of CM. The basic scenario was based on data from 5 large 
herds  in  New  York  State.  In  the  basic  scenario  92%  of  the  CM  cases  were 
recommended to be treated. The average cost per CM case in these herds was $179. It 
was composed of $115 due to milk yield losses, $14 due to increased mortality, and 
$50 due to treatment associated costs. The estimated cost of CM was highly dependent 
on cow traits: it was highest ($403) in cows with high expected value (e.g., young, 
high milk yielding cows), and was lowest ($3) in cows low expected future net returns 
(i.e. were recommended to be culled). The cost per case of CM was 18% higher with a 
20% increase in milk price and 17% lower with a 20% decrease in milk price. The cost 
per  episode  of  CM  was  little  affected  by  a  20%  change  in  replacement  cost  or 
pregnancy rate. Changes in CM incidence, however, resulted from changes in these 
factors, thus affecting whole farm profitability. The detailed results obtained from this 
insemination and replacement optimization model can assist farmers in making CM 
treatment decisions.  
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INTRODUCTION 
Low profit margins in the dairy industry provide incentives to dairy producers to 
make  good  economic  decisions  in  general  and  apply  sound  economic  disease 
management  decisions  in  particular.  To  achieve  this,  relevant  estimations  about 
disease costs have to be determined. These estimations can then be utilized in the 
evaluation  of  benefits  of  applying  preventive  measurements  to  decrease  disease 
incidence and/or disease losses, and in the process allow the evaluation of individual 
cow disease treatment options. Static models have limited usefulness in estimating 
disease  costs  given  the  dynamics  of  the  cow  herd;  dynamic  models  that  permit 
modeling  herd  dynamics  are  much  more  appropriate  (Seegers  et  al.,  2003).  Such 
dynamic models have been developed and used to address herd replacement decisions. 
Using a dynamic programming (DP) model, De Vries (2006) estimated the retention 
pay off (RPO) of open and pregnant cows that were identical in other traits. The 
difference  was  therefore  the  value  of  pregnancy  in  specific  cows.  The  price  of 
pregnancy was shown in this study to vary greatly between individual cows and under 
different herd parameters. Such dynamic models of the cost of a disease are relatively 
scarce; on mastitis, undoubtedly the disease with the highest economic importance, 
only a few have appeared in the literature. Yalcin and Stott (2000) calculated the cost 
benefit of whole herd mastitis preventive measurements using a small DP model with 
a stage length of only one lactation. Their model enabled replacement of cows only at 
the end of the lactation, and was therefore not detailed enough to support individual 
cow decision support. The model of Houben et al. (1994), used for estimating the 
optimal  handling  of  mastitic  cows,  is  probably  the  most  comprehensive  animal 
replacement DP model reported to date. The state space of their model was almost 7 
million, representing a large amount of realistic complexity; thus providing detailed 
individual cow mastitis (as well as fertility and productivity) decision support. Several  
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reasons encourage us to repeat and extend this estimation effort:  
4.  New data on the effects of mastitis suggests a different model structure than in 
Houben’s model: The effect of mastitis on production (Gröhn et al., 2004) and on 
the  risk  of  culling  (Gröhn  et  al.,  2005)  is  time  dependent.  Impact  on  milk 
production  and  culling  is  high  close  to  disease  occurrence  and  tapers  off  after 
about 2 months. 
5.  In Houben’s model, the milk loss in the first month after clinical mastitis (CM) 
was assumed to be reduced by 40% in primipara and 50% in multipara. This would 
result in today’s high yielding dairy cow having a loss of more than 750 kg milk in 
the first month following CM. Our estimates are considerably lower (Gröhn et al., 
2004).  
6.  The current milk production of dairy cows is about 4,000 kg more than estimated 
in Houben et al. (1994). In addition, there seems to be a shift in mastitis causing 
agents (less contagious, more environmental) in the past 10 years in modern dairy 
herds (Makovec and Ruegg, 2003). 
7.  We have new information concerning the effects of repeated CM within and 
between lactations (Bar et al., 2007). 
The hypothesis of this study was that the cost of CM varies greatly for individual 
cows, depending on the performance of the cow, the lactation number, the stage of 
lactation,  pregnancy  status,  prices,  and  breeding  and  replacement  options.  A  more 
informed  decision  making  process  in  CM  management  is  possible  through  better 
understanding  of  these  relationships.  Using  more  current  knowledge  and  data,  the 
objectives  of  this  study  are  to  estimate  CM  costs  in  relation  to  individual  cow 
characteristics, to calculate expected whole herd costs, and to relate these costs to 
exogenous parameters like milk price, replacement costs or pregnancy rates, using a 
newly constructed DP model.   
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MATERIALS AND METHODS 
Herds Description 
We used data from 5 dairy farms located in NY State. These farms milked an 
average of 1,200, 1,100, 750, 650 and 600 Holstein milking cows and were followed 
for approximately 24 months. The rolling herd average was close to 11,000 kg per 
cow/yr on a 305 d basis (range 10,700 to 11,500); monthly mean SCC was 225,000 
cells/mL (monthly range, 180,000 to 355,000), and varied little among the 5 farms. 
Cows were housed in covered barns with concrete floors and free stalls. All groups of 
cows were fed a balanced TMR via feed alleys. Cows were milked 3 times per day. 
Each  milking  unit  had  milk  meters  capable  of  automatically  recording  milk 
production. Reliable data were readily  available on parity, diseases, inseminations, 
drying off, calving, and exit from the herd, since those data were also used by herd 
personnel  to  manage  the  dairy  herd.  All  milkers  on  the  cooperating  farms  were 
familiar with detection of CM by examination of foremilk. Some cases of CM were 
identified by milkers (warm, swollen udder or changes in the milk) while others were 
detected by the herdsperson examining cows’ performance. Farm personnel sampled 
milk for microbiological culture from quarters with signs of CM. The samples were 
usually collected daily and were cultured by the Quality Milk Production Services 
laboratories. 
  
Replacements and inseminations optimization and simulation model  
Programming  tools:  Our  model  was  built  using  the  Multi  Level  Hierarchic 
Markov Process (MLHMP) software (Kristensen, 2003) as the application program 
interface. This software has been used in building and solving various dynamic models 
(Nielsen  et  al.,  2004;  Kristensen  and  Sollested,  2004).  The  MLHMP  software  
 76   
combines  the  properties  of  policy  iteration  and  value  iteration  in  solving  the  DP 
model. Policy iteration is fast converging for infinite time problems, but can be used 
only for a relatively small state space as the solution involves matrix inversion; it is 
used in the founder (parent) level of the Markov process. Value iteration on the other 
hand is capable of solving very large state space models for a finite time horizon, and 
is used in the child processes, which are of finite time horizon because no animal lives 
forever. Since the MLHMP software visualizes the model tree with a graphic interface 
along  with  detailed  representation  of  the  various  stage state  combinations,  model 
building and debugging is greatly facilitated. Our model was used as a plugin into the 
MLHMP software, which in turn constructs the model with the plugin specifications.  
Model  Structure:  The  model  was  constructed  as  a  3 level  hierarchic  Markov 
process. The schematic structure is graphically illustrated in Figure 5.1. The founder 
(parent) level is of infinite time horizon and contains state variables that are permanent 
traits throughout the life span of a cow. The child level is divided into time steps 
(stages) each representing one whole lactation (its length is determined by the next 
level).  State  variables  in  this  second  level  are  permanent  traits  throughout  the 
lactation.  The  grandchild  level  is  divided  into  stages  of  one  month  duration. 
Exceptions are a short after calving stage of 3 d, a dry period stage of 2 mo, and a 
dummy stage of length zero if the cow is to be dried off. State variables in this third 
level are permanent only for each time step. Possible actions can be taken at this level. 
In our model 3 actions were possible: 1. Replace the cow with a calving heifer. 2. 
Keep the cow for another month without insemination (and treat the cow if she has 
CM). 3. Inseminate the cow for another month (after the voluntary waiting period that 
was set to 2 mo). 
Stage  and  State  Variables:  In  the  founder  level  (parent)  5  milk  yield  levels 
(permanent milk producing ability) are modeled as: +5, +2.5, 0,  2.5, and  5 kg from  
 77   
the  mean  level  of  milk  production  per  day.  In  the  child  level  8  possible  whole 
lactations  stages  are  modeled  with  2  carry over  mastitis  states  from  the  previous 
lactation (yes/no). In the grandchild level 20 lactation stages are modeled (maximum 
calving interval of 20 mo) as 5 temporary milk yield levels (+4, +2, 0,  2, and  4 kg 
milk  per  day  relative  to  the  permanent  milk  yield);  9  pregnancy  status  levels 
(0=empty, 1 7 mo pregnant, and 8=dry); one involuntarily culled state; and 13 mastitis 
states. The mastitis states were defined as follows: 0=no mastitis, 1 = first occurrence 
of CM (observed at the end of the stage), 2, 3, 4 corresponding to 1, 2, 3 and more 
months after first CM respectively, 5 = second occurrence of CM, and so forth. CM 
events after the third occurrence were modeled as being again a third CM case. After 
excluding most impossible combinations (e.g. 6 mo pregnant and 3 mo in lactation), 
the  model  described  560,725  stage state  combinations.  The  objective  function 
maximized  by  the  model  was  the  discounting  criterion  (Kristensen,  2003)  using  a 
yearly interest rate of 8%. 
 
Model parameters  
Prices: Prices for milk, beef, variable costs, fixed costs, and feed cost were taken from 
De Vries (2006) to facilitate comparison of the results with his results. Different prices 
would result in a different solution. In our DP model we separated the cost of a cow 
kept in the herd into 2 components: a $150 fixed cost of keeping a cow for a month 
regardless of production level (7 kg lactating ration DMI per day and all operating and 
fixed costs), and a. $0.222 net returns per kg milk (milk price minus feed price to 
produce 1 kg of milk). This was done for modeling simplicity instead of having a 
separate bio economic module as in De Vries (2006). The full beef price ($400) was 
assumed  for  cows  in  late  lactation  that  were  culled  by  model  recommendation.  A 
discount factor (range 0.8 1.0) was used to adjust this beef price for cows in the first 7  
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months of the lactation (due to lower body weight and body condition score). Cows 
that were forced to be culled (because of decisions not determined by the model) were 
assumed to receive 50% of the beef price at the first month after calving, and 65% 
afterwards. This discounting was based upon the ratio of cows dying on the farms and 
cows sold to a beef handler found in the 5 study farms (D. Bar, unpublished data).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Schematic representation of the replacement and insemination optimization 
model used in this study to estimate clinical mastitis costs. 
 
Milk  yields:  Lactation  curves  were  estimated  using  135,166  weekly  average  milk 
yields from 10,380 lactations in the 5 study farms (Bar et al., 2007). Lactations were 
expressed in the DP model as the actual yields in the first 3 months and a constant 
linear negative slope afterwards; because that was the functional form (at least in the 
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first 52 weeks of the lactation) estimated in the study farms (Bar et al., 2007). Values 
for the first lactation were 26.3, 34.4, and 36.8 kg milk per day in the first 3 months 
respectively, and a loss of 0.9 kg for each additional month afterwards. For the 2
nd 
lactation, the corresponding estimates were 39.1, 47.7, 46.6, and a negative slope of 
2.25. For the 3
rd lactation, these estimates were 40.3, 48.9, 47.8, and a negative slope 
of 2.3. Older cows were penalized for lactation beyond 3 with 0.75 kg milk reduction 
per day. 
We chose to model the actual milk yield of cows into two separate components: 
the expected milk yield level (first level in the Markov process) and a deviation from 
this estimate (third level). Such a separation was not considered in any previous dairy 
DP  model.  The  reason  for  this  approach  was  that  farmers  often  evaluate  the 
performance of their cows as deviation from expectations or past performance; they 
have some prior knowledge about the cow (from her genetic potential and previous 
milk yield) and they observe the current milk yield in relation to this prior knowledge. 
Situations like higher milk loss because of CM than the estimated average were easily 
modeled as deviations. 
Transition probabilities: the transition between the monthly observed relative milk 
yield levels followed a normal distribution with mean equal to the permanent milk 
yield  level  and  the  variance  estimated  from  the  study  farms.  For  example  the 
transitions probabilities to the five temporary milk yield levels +4, +2, 0,  2, and  4 kg 
milk per day in the next month for a cow currently at milk level 0 were 0.07, 0.24 
0.38, 0.24, and 0.07 respectively; for a cow currently at level +4 the corresponding 
probabilities were 0.69, 0.24, 0.06, 0.01, and 0.00 respectively. A replacement heifer 
was assumed to have a permanent milk yield level following a normal distribution that 
is slightly skewed to simulate the expected genetic improvement (equivalent to 100 kg 
higher 305 days milk production per generation) of replacement animals.  
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The probability of a cow to be pregnant in a following month was set to 0.21 if a 
decision was made to inseminate the cow. Since we did not consider abortion in our 
model and our pregnancy rate was constant, we used a slightly lower rate than De 
Vries (2006), to reach the same proportion of cows pregnant at the end of lactation.  
Exit from the herd: In the model, a cow could leave the herd because of 2 distinct 
reasons: The model recommended culling, or exit from the herd from causes that were 
not model determined, but forced with some probability. These causes included dead 
cows (including euthanized cows), and cows sold for slaughter because of reasons 
other  than  milk  yield,  pregnancy,  and  mastitis  (e.g.  injuries,  calving  diseases,  and 
lameness). The risks of forced exit were calculated from 16,145 lactations in the study 
farms (D. Bar, unpublished data). In the DP model they were slightly simplified as a 
constant monthly risk of 0.006, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, and 0.07 for the 1
st, 
2
nd, 3
rd, 4
th, 5
th, 6
th, 7
th, and 8
th lactation respectively. A mortality of 2% was added in 
the after calving stage (first 3 days after calving).  
Effects  of  clinical  mastitis:  The  effects  of  CM  were  calculated  from  the  5  study 
farms. The milk losses associated with repeated cases of CM are detailed in Bar et al., 
(2007) and are summarized in Table 5.1 as the milk loss in the 1
st month, the 2
nd 
month, and the 3
rd month and later after CM. The mortalities associated with CM were 
calculated from 16,145 lactations in the study farms (Chapter 3). In the DP model hey 
were simplified as 1% mortality in primiparous cows and 2% in multipara. A decision 
to treat the CM cow was associated with a cost of $50. This cost was an estimated 
average due to drugs ($20), the decreased value of 5 days worth of discarded milk 
from an average production cow ($20), and extra labor ($10). The monthly risks of 
CM  used  in  the  DP  model  are  summarized  in  Table  5.2.  These  were  a  slight 
simplification  of  the  estimates  obtained  from  the  study  farms  (Chapter  4).  In  that 
study,  the  odds  ratio  of  a  cow  that  had  CM  in  her  previous  lactation  to  again  
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experience a CM case, was very high (about 10); we chose to use 5 in the DP model, 
because we believed it should not be higher than the risk of the reoccurrence within 
the same lactation.  
 
Table 5.1. Milk loss (kg) from Generic clinical mastitis (CM) cases in the first 2 
months following CM, with milk loss constant after the second month. 
 
Parity  Days  1st CM  2nd CM  3rd CM 
1  0 30  116  137  137 
   31 60  67  76  76 
   >61  64  24  24 
         
2+  0 30  183  186  162 
   31 60  92  73  76 
   >61  73  43  52 
Source: Bar et al., 2007 
 
Methodology of estimating CM cost: 
Average cost of CM in the herd: the average net returns per cow per year for a herd 
without  CM  was  compared  to  the  average  net  returns  for  a  herd  with  the  same 
parameters but with the given CM risk. The profit loss was then divided by the model 
simulated CM incidence to get the cost per one CM case. It is important to realize that 
this is a lower bound estimate of the cost of CM since the model minimizes the cost of 
CM under optimal treatment decisions. Actual farm experiences may differ from this 
optimal. 
Cost of CM in individual cows: RPO (given the optimal breeding and replacement 
policy) of 2 cows that  are categorized similarly  but that differ in CM status were 
compared to get the estimated profitability loss for a CM cow. 
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Table  5.2.  Monthly  risks  (probability)  for  CM  occurrence  in  the  dynamic 
programming model, estimated from 16,145 lactations in 5 NY State dairy herds. 
Parity  Days1  1
st
 CM  2nd CM  3rd CM 
1  0 30  3%  5%  9% 
   31 60  1%  2%  8% 
   61 91  1%  2%  4% 
   >91  1%  2%  3% 
         
2  0 30  4%  9%  12% 
   31 60  2%  7%  10% 
   61 91  2%  4%  8% 
   >91  2%  4%  7% 
         
3  0 30  5%  10%  14% 
   31 60  3%  8%  12% 
   61 91  3%  5%  9% 
   >91  3%  5%  8% 
         
4+  0 30  6%  12%  16% 
   31 60  4%  10%  14% 
   61 91  4%  6%  10% 
   >91  4%  6%  9% 
1 Days after calving for the 1st CM case. Days after previous CM for repeated CM 
cases; Source: Chapter 4 
 
RESULTS 
Components of CM costs  
The simulated herd results before and after assigning the milk loss in the current 
lactation, the expected milk loss into the next lactation, the increased mortality, and 
the assigned treatment cost into the DP model are detailed in Table 5.3.  The average 
cost of CM in our study herds was $71 per cow and year ($426 $355) and $179 per 
CM case ($71/0.397). It was composed of $115 due to milk loss, $14 due to increased 
mortality and $50 due to treatment associated costs. In the basic scenario 92% of the 
CM cases were recommended to be treated.    
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With each CM effect added to the model, whole herd profitability, milk yield and 
herd life were reduced. The percentage of CM treated (i.e. were recommended to be 
kept in the herd) was lower with the added CM effects.  
 
Table 5.3. Simulated whole herd parameters as a result of assigning the effects of 
clinical mastitis (CM) sequentially to the optimization and simulation model 
 
  
$ Net 
Return
1   
Milk 
yield 
2 
Forced 
exit
3 
Model 
exit
4 
Herd 
life
5 
CM 
cases
6 
% of 
CM 
treated
7 
Cost 
per 
case
8 
No CM in Model 
  426  11,565  19.0  14.4  36.7  0.0  0.0  0 
Sequential Changes to the Model and Resultant Cumulative Impacts of each Change 
Milk loss in the 
current lactation  393  11,442  18.5  15.5  35.9  43.0  96.2  77 
Milk loss in the 
following lactation 
378  11,397  18.2  16.4  35.4  41.8  95.4  115 
Mortality  373  11,398  18.7  16.3  35.0  41.1  95.9  129 
Treatment cost  355  11,424  18.3  17.3  34.4  39.7  91.9  179 
Combined impact of CM compared to No CM under Optimal Decisions 
   71   145   0.7  +2.9   2.3      179 
1 net returns in USD per cow and year 
2 kg milk per cow and year 
3 annual exit (%) from the herd from causes that were not model determined 
4 annual exit (%) from model recommended culling 
5 average herd life (from first calving to exit from the herd) in months 
6 incidence of CM (cases per 100 cows and year) 
7 percent of treated CM cows per CM cows 
8 average cost per CM case following an optimal replacement policy.  
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Exogenous factors affecting CM cost  
The cost of CM is dependent on exogenous factors (Table 5.4). A higher milk 
price is associated with a higher CM cost. The cost per case of CM was 18% higher 
with a 20% increase in milk price and 17% lower with a 20% decrease in milk price. 
Higher milk price increased culling rate, increased culling of CM cows, and decreased 
CM incidence as a result. Lower replacement heifer price changed the cost per CM 
case only slightly, but the effect of CM on whole herd profitability decreased because 
the incidence of CM was reduced substantially through  a higher replacement rate. 
Moderate changes in pregnancy rate changed the cost per CM case very little; but had 
a moderate effect on CM incidence. Higher pregnancy rate resulted in higher CM 
incidence.  
 
Optimal breeding and replacement policy  
The last month determined in the model for insemination and keeping the cow in 
the herd for open cows with clinical mastitis and for open cows without CM is given 
in  Table  5.5.  Cows  of  higher  expected  milk  yield  are  recommended  for  longer 
insemination period and extended herd life. CM cows were recommended for a shorter 
breeding period and shorter time to be kept in the herd. A lower temporary observed 
milk yield than the expected yield generally shortened these periods by a month for 
each 2 kg of milk per day (results not shown).   
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Table  5.4.  The  effects  of  changes  in  milk  price,  replacement  heifer  cost,  and 
pregnancy rates on whole herd dynamics obtained by probabilistic Markov chain 
simulation following an optimal insemination and replacement policy.   
 
$ Net 
Return
1   
Milk 
yield 
2 
Forced 
exit
3 
Model 
exit
4 
Total 
exit  
CM
5 
cases
6 
% of 
CM 
treated
7 
Cost 
per 
case
8 
Basic 
scenario 
355  11,424  18.3  17.3  35.6  39.7  91.9  179 
                 
Milk price 
+20% 
  1048  11,564  17.6  21.4  39.0  37.8  90.2  212 
Milk price 
 20% 
   330  11,284  19.3  13.6  32.9  42.3  94.0  149 
                 
Replacement 
cost +20% 
242  11,283  19.5  13.4  32.9  42.6  94.5  183 
Replacement 
cost  20% 
482  11,653  16.8  24.9  41.7  35.7  87.9  179 
                 
Pregnancy 
rate +20% 
387  11,445  19.2  14.6  33.8  41.7  92.3  177 
Pregnancy 
rate  20% 
309  11,403  17.1  21.3  38.4  36.9  91.1  182 
1 net returns in USD per cow and year 
2 kg milk per cow and year 
3 annual exit (%) from the herd from causes that were not model determined 
4 annual exit (%) from model recommended culling 
5 CM: clinical mastitis 
6 incidence of CM (cases per 100 cows and year) 
7 percent of treated CM cows per CM cows 
8 average cost per CM case following an optimal replacement policy.  
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Table 5.5. Last month recommended for insemination and keeping the cow in the 
herd for open cows with clinical mastitis (CM) and for open cows without CM. 
The decision to keep (or inseminate) a CM cow involves the cost of treatment.  
      Permanent production potential 
      <  5 kg
1  Average  > +5 kg 
Parity     Inseminate  Keep  Inseminate  Keep  Inseminate  Keep 
No CM  8  8  11  13  11  17 
1 
CM  DNB2  4  11  11  11  13 
No CM  DNB  8  10  12  11  13 
3 
CM  DNB  6  7  8  11  11 
No CM  DNB  7  6  10  11  12 
5 
CM  DNB  4  DNB  6  9  9 
1 per day   
2 DNB= Do Not Breed  
 
RPO of open healthy and CM cows  
RPO  of  two  example  cows  (third  lactation,  open,  with  average  expected  and 
observed milk  yield), one with CM in this month, the other free of CM until this 
month, as a function of month after calving are presented in Figure 5.2. Best policy 
recommended by the model is also presented in this graph. The RPO of these cows 
decreased from $1060 and $755 respectively at calving to a value under $0 (at 12 
month for CM free cows, and 8 months for cows with CM). A negative RPO means 
that  cows  were  recommended  to  be  culled.  The  cost  of  CM  in  these  cows  was  
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therefore $305 at calving, $236 at 6 month after calving, and close to zero if CM 
occurred  a  year  after  calving  (because  the  cow  was  recommended  to  be  culled 
anyway). 
 
 
 
 
 
 
Figure 5.2. Retention payoffs under optimal policy for a cow free of clinical mastitis 
(CM) (solid line) and a cow that incurred CM in the same month (dotted line) by 
months after calving. Cows are in their third lactation with average lactation curves. 
Cost of CM is equal to the difference between the RPO of the healthy and CM 
diseased cow in the same month after calving. 
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DISCUSSION 
The  objectives  of  this  study  were  to  estimate  CM  associated  costs  and  the 
dependence of these costs on cow and herd related factors. The average cost of CM in 
our study herds was $179. It was composed of $115 due to milk loss, $14 due to 
increased mortality and $50 due to treatment associated costs. In the basic scenario 
92% of the CM cases were recommended to be treated. The estimated cost of CM was 
highly dependent on cow traits (range: $3 $403). The cost of a CM case was higher 
with increased milk price. The cost per episode of CM was little affected by a 20% 
change in replacement cost or pregnancy rate; however, these changes influenced the 
CM incidence, thereby changing CM costs at the herd level.  
The values calculated here are relevant for the structure, parameters, and prices 
utilized. As underlined by Seegers et al. (2003), any mastitis cost estimation in a herd 
is, per se, of low external validity. Despite this it is interesting that the 2 previously 
published  dynamic  models  addressing  CM  estimated  similar  costs.  Houben  et  al. 
(1994), using DP, estimated the loss per cow in the herd because of CM at $83 with an 
incidence of 36.5 cases per 100 cow years. Østergaard et al. (2005), using dynamic 
simulation, estimated this cost at $90 with an incidence of 42 CM cases per 100 cow 
years (using a higher milk price than used in our basic scenario), and our estimate is 
$71 with an incidence of 39.7 CM cases per 100 cow years. It is of note that we used 
data from farms that used a J5 vaccine that had been shown to reduce the milk loss 
associated with Gram negative CM (Wilson et al., 2007).  
The high dependence of disease cost on individual cow characteristics should not 
come as a surprise, although it has been rarely documented before (Seegers et al., 
2003). Mastitis affecting a cow that should be replaced anyway has a low cost (only 
the increased mortality risk comes into play). The highest mastitis cost is with cows of 
high future expected income. Treatment of such cows can be justified even with high  
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treatment costs. The average milk loss per CM case calculated by dynamic models is 
therefore less than attributed in traditional static models. In fact, static models that add 
milk loss, increased culling costs, and treatment costs to all CM cases are actually 
more than double counting costs: not all cows will experience the full estimated milk 
loss associated with CM, the increased culling is to a large extent a voluntary decision 
of the farmer, and not all cows with CM will even incur treatment costs. 
The  cost  of  CM  is  dependent  on  exogenous  factors.  A  higher  milk  price  is 
associated with a higher CM cost. This is because the value of the milk loss associated 
with CM has a higher monetary value. Lower replacement heifer price changed the 
cost  per  CM  case  only  slightly,  but  the  effect  of  CM  on  whole  herd  profitability 
decreased because the incidence of CM was reduced substantially through a higher 
replacement rate (because of lower replacement costs). The effect of fertility on CM 
incidence  might  be  less  intuitive:  higher  pregnancy  rate  resulted  in  higher  CM 
incidence. This is because a higher pregnancy rate means a higher chance of a cow 
surviving  in  the  herd.  A  cow  with  higher  expected  milk  yield  is  therefore  more 
valuable and is recommended to be treated and kept in the herd despite CM.  
Like every model, the one developed here is a simplification of the real world. It 
was targeted for CM cost evaluation. A detailed representation of the varying costs of 
keeping  a  cow  throughout  her  lifespan  and  a  decreasing  marginal  feed  efficiency 
(without the cost of keeping the cow in the herd) for high producing cows was not 
modeled. This bonus for high milk yield cows is somewhat “compensated” by not 
considering  a  higher  pregnancy  value  for  cows  with  high  permanent  potential 
(improved  future  replacement  heifers).  We  did  not  model  seasonality  and  milk 
component  variations,  nor  the  exact  shape  of  the  lactation  curves  for  very  long 
lactations. Addressing such issues was outside the scope of our objectives and might 
confound CM effects.  
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DP models such as ours are difficult to validate (Seegers et al., 2003).  In this 
respect it is interesting to note that our model gave the same whole herd profitability, 
culling rates, and elasticity of these parameters as the model developed by De Vries 
(2006). This was in spite of the differences of these 2 models in their structure (De 
Vries’s model is not hierarchic and uses only value iteration), in the way milk yield is 
modeled (we used a linear decline of milk yield after peak production instead of a 
diphasic production function), in fertility modeling (abortion was not considered in 
our model), and in the culling rates for model unrelated reasons (mainly because CM 
was  part  of  the  involuntary  culling  in  the  De  Vries  model).  The  simulated  herd 
dynamics after optimal policy were also in agreement with the actual study herds’ 
dynamics. This is an indicator that the farmers in our study herds followed intuitively 
(at least in general) the best economic policy regarding breeding and culling decisions. 
In that case, our estimates of CM cost computed from an optimization model may be 
an unbiased estimate of the actual cost on well managed farms.  
Since our program enables editing parameters before actual model building, the 
same model can be used to calculate disease costs under other dairy parameters. The 
model  developed  here  is  not  restricted  to  the  investigation  of  mastitis  economics. 
Similar diseases like lameness can be evaluated within the same model with necessary 
parameter changes. For the estimation of calving disease costs, an even simpler model 
would be adequate (because a calving disease occurs only once per lactation and in the 
same time period for all cows affected). 
Dynamic models such as the one presented here have the potential to become a 
useful  decision  aid  tool  in  disease  management,  because  the  results  are  not  only 
expressed as a recommended policy, but are also expressed as opportunity costs. By 
combining  model  results  with  additional  factors  (such  as  information  about  SCC, 
estimated individual cow’s beef price), real time quantitative decisions are possible.  
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To achieve a well informed individual cow decision, a more detailed representation of 
the milk yield of the cow would be useful. The current model is designed for whole 
herd CM cost estimation and whole herd dynamics. It is therefore more useful for 
evaluating the average cost of a disease in a farm, or the cost benefit of applying 
preventive measurements like vaccination. 
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ABSTRACT 
The objective of this study was to demonstrate possible applications of a specially 
structured  replacement  optimization  and  simulation  model  that  included  a  detailed 
representation  of  repeated  episodes  of  clinical  mastitis  (CM)  in  assisting  CM 
treatment decisions. The basic scenario was based on data from 5 large dairy herds in 
New York State. Sub optimal replacement policies were evaluated. Compared to the 
model  recommended  optimal  policy,  a  decision  to  treat  all  cows  with  CM  (i.e. 
postpone replacement decision to the next month) resulted in an additional cost of $2 
per cow per year. A policy of replacing all CM cows after their 2
nd CM case resulted 
in an additional cost of $27 per cow per year, and if replacing all cows after their 3
rd 
CM case this estimate was $8. The cost benefit of applying two fictitious vaccinations 
were calculated. A vaccination that would result in reducing the milk loss caused by 
Gram negative CM by 50% was allowed to cost $14 per cow per year. A vaccination 
that would result in additional reduction of the risk of CM by 50% was allowed to cost 
$37 per cow per year. Comparing expected net present values obtained from the model 
for cows with similar traits but differing in CM state and pregnancy status can assist 
the farmer in making quantitative economic CM treatment decisions. 
 
INTRODUCTION 
Low profit margins in the dairy industry provide incentives to dairy producers to 
make  good  economic  mastitis  treatment  decisions.  To  achieve  this,  relevant 
estimations about disease costs have to be determined. These estimations can then be 
utilized in making individual cow disease management decisions, and in the process 
allow the evaluation of benefits of applying preventive measures to decrease disease 
incidence and/or disease losses. Static models have limited usefulness in estimating 
disease  costs  given  the  dynamics  of  the  cow  herd;  dynamic  models  that  permit  
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modeling  herd  dynamics  are  much  more  appropriate  (Seegers  et  al.  (2003).  Such 
dynamic models have been developed and used to address herd replacement decisions 
that  included  information  about  disease  status  in  general  (Gröhn  et  al.,  2003)  or  
information specific to mastitis status (Houben et al., 1994; Stott et al., 2002; Yalcin 
and Stott, 2000)  
We  recently  constructed  a  comprehensive  replacement  optimization  and 
simulation  model  that  included  a  detailed  representation  of  repeated  episodes  of 
clinical  mastitis  (CM)  to  estimate  CM  costs  in  high  milk  producing  dairy  cows 
(Chapter 5). It was shown that the cost of CM varied greatly for individual cows, 
depending on the performance of the cow, the lactation number, the stage of lactation, 
pregnancy status, prices, and breeding and replacement options. 
The hypothesis of this study is that the DP framework provides an opportunity to 
assist farmers and bovine practitioners in making quantitative CM treatment decisions. 
The objective of this study is to explore some of the possible applications of this 
framework. 
 
MATERIALS AND METHODS 
Herds Description 
We used data from 5 dairy farms located in New York State. These farms milked 
an  average  of  1,200,  1,100,  750,  650  and  600  Holstein  milking  cows  and  were 
followed for approximately 24 months. The rolling herd average was close to 11,000 
kg per cow/yr on a 305 d basis (range 10,700 to 11,500); monthly mean SCC was 
225,000 cells/mL (monthly range, 180,000 to 355,000), and varied little among the 5 
farms. Cows were housed in covered barns with concrete floors and free stalls. All 
groups of cows were fed a balanced total mixed ration via feed alleys. Cows were  
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milked 3 times per day. Each milking unit had milk meters capable of automatically 
recording milk production. Reliable data were readily available on parity, diseases, 
inseminations, drying off, calving, and exit from the herd, since those data were also 
used by herd personnel to manage the dairy herd. All milkers on the cooperating farms 
were familiar with detection of CM by examination of foremilk.  Some cases of CM 
were identified by milkers (warm, swollen udder or changes in the milk) while others 
were  detected  by  the  herdsperson  examining  cows’  performance.  Farm  personnel 
sampled  milk  for  microbiological  culture  from  quarters  with  signs  of  CM.  The 
samples  were  usually  collected  daily  and  were  cultured  by  the  Quality  Milk 
Production Services laboratories. 
 
Replacements and inseminations optimization and simulation model  
Programming tools: Our model was built using the Multi Level Hierarchic Markov 
Process (MLHMP) software (Kristensen, 2003) as the application program interface. 
The  model  was  programmed  as  a  plugin  in  the  MLHMP  software,  which  in  turn 
constructs the model with the plugin specifications.  
Model structure: The model was constructed as a 3 level hierarchic Markov process. 
The founder (parent) level is of infinite time horizon and contains state variables that 
are permanent traits throughout the life span of a cow. The first child level is divided 
into time steps (stages) of one lactation (its length is determined by the next level). 
State variables in this second level are permanent traits throughout the lactation. The 
second  child  level  (grandchild)  is  divided  into  stages  of  one  month  duration. 
Exceptions are a short after calving stage of 3 days, a dry period stage of 2 months, 
and a dummy stage of length zero if the cow is to be dried off. State variables in this 
third level are permanent only for each time step. Possible actions can be taken at this 
level. In our model 3 actions were possible: 1. Replace the cow with a calving heifer;  
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2. Keep the cow for another month without insemination (and treat the cow if she has 
CM); and 3. Inseminate the cow for another month (after the voluntary waiting period 
that was set to 2 months). 
Stage  and  state  variables:  In  the  founder  level  (parent)  5  milk  yield  levels 
(permanent milk producing ability) are modeled as: +5, +2.5, 0,  2.5, and  5 kg from 
the  mean  level  of  milk  production  per  day.  In  the  child  level  8  possible  whole 
lactations  stages  are  modeled  with  2  carry over  mastitis  states  from  the  previous 
lactation (yes/no). In the grandchild level 20 lactation stages are modeled (maximum 
calving interval of 20 mo) as 5 temporary milk yield levels (+4, +2, 0,  2, and  4 kg 
milk  per  day  relative  to  the  permanent  milk  yield);  9  pregnancy  status  levels 
(0=empty, 1 7 mo pregnant, and 8=dry); one involuntarily culled state; and 13 mastitis 
states. The mastitis states were defined as follows: 0=no mastitis, 1 = first occurrence 
of CM (observed at the end of the stage), 2, 3, 4 corresponding to 1, 2, 3 and more 
months after first CM respectively, 5 = second occurrence of CM, and so forth. CM 
events after the third occurrence were modeled as being again a third CM case. After 
excluding most impossible combinations (e.g. 6 mo pregnant and 3 mo in lactation), 
the  model  described  560,725  stage state  combinations.  The  objective  function 
maximized  by  the  model  was  the  discounting  criterion  (Kristensen,  2003)  using  a 
yearly interest rate of 8%; i.e. the model recommended a policy that maximized the 
expected net present value (NPV) of the cow (and her replacement heifers). After 
optimization, expected whole herd dynamics were calculated by using probabilistic 
Markov chain simulations implemented in the MLHMP software.   
Model parameters  
Prices: Prices for milk, beef, replacement heifer cost, calf price, variable costs, fixed 
costs, and feed cost were taken from De Vries (2006). Different prices would result in 
a different solution. In our DP model we separated the cost of a cow kept in the herd  
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into 2 components: a $150 fixed cost of keeping a cow for a month regardless of 
production level (7 kg lactating ration DMI per day and all operating and fixed costs), 
and a. $0.222 net returns per kg milk (milk price minus feed price to produce 1 kg of 
milk).  This  was  done  for  modeling  simplicity  instead  of  having  a  separate  bio 
economic module as in De Vries (2006). The full beef price ($400) was assumed for 
cows  in  late  lactation  that  were  culled  by  model  recommendation.  An  adjustment 
factor (range 0.8 1.0) was used to adjust this beef price for cows in the first 7 months 
of the lactation (due to lower body weight and body condition score). Cows that were 
forced to be culled (because of decisions not determined by the model) were assumed 
to receive 50% of the beef price at the first month after calving, and 65% afterwards. 
This discounting was based upon the ratio of cows dying on the farms and cows sold 
to a beef handler found in the 5 study farms (Chapter 3).  
Milk  yields:  Lactation  curves  were  estimated  using  135,166  weekly  average  milk 
yields from 10,380 lactations in the 5 study farms (Bar et al., 2007). Lactations were 
expressed in the DP model as the actual yields in the first 3 months and a constant 
linear negative slope afterwards, because that was the functional form (at least in the 
first  52  weeks  of  the  lactation)  estimated  in  the  study  farms.  Values  for  the  first 
lactation were 26.3, 34.4, and 36.8 kg milk per day in the first 3 months respectively, 
and a loss of 0.9 kg per day for each additional month afterwards. For the 2
nd lactation, 
the corresponding estimates were 39.1, 47.7, 46.6, and a negative slope of 2.25. For 
the 3
rd lactation, these estimates were 40.3, 48.9, 47.8, and a negative slope of 2.3. 
Older cows were penalized for lactations beyond 3 with a 0.75 kg milk reduction per 
day. We chose to model the actual milk yield of cows as two separate components: the 
expected milk yield level (first level in the Markov process) and a deviation from this 
estimate (third level). Such a separation was not considered in any previous dairy DP 
model. The reason for this approach was that farmers often evaluate the performance  
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of their cows as deviations from expectations or past performance; they have some 
prior knowledge about the cow (from her genetic potential and previous milk yield) 
and they observe the current milk yield in relation to this prior knowledge. Situations 
like higher milk loss because of CM than the estimated average were easily modeled 
as deviations. 
Transition probabilities: the transition between the monthly observed relative milk 
yields levels followed a normal distribution with mean equal to the permanent milk 
yield  level  and  the  variance  estimated  from  the  study  farms.  For  example,  the 
transition probabilities to the five temporary milk yield levels +4, +2, 0,  2, and  4 kg 
milk per day in the next month for a cow currently at milk level 0 were 0.07, 0.24, 
0.38, 0.24, and 0.07 respectively; for a cow currently at level +4 the corresponding 
probabilities were 0.69, 0.24, 0.06, 0.01, and 0.00 respectively. A replacement heifer 
was assumed to have a permanent milk yield level following a normal distribution that 
is slightly skewed to simulate the expected genetic improvement (equivalent to 100 kg 
higher  305 day  milk  production  per  generation)  of  replacement  animals.  The 
probability of a cow becoming pregnant in the following month was set to 0.21 if a 
decision was made to inseminate the cow.  
Exit from the herd: In the model, a cow could leave the herd because of 2 distinct 
reasons: The model recommended culling, or exit from the herd from causes that were 
not model determined, but forced with some probability. These causes included dead 
cows (including euthanized cows), and cows sold for slaughter because of reasons 
other  than  milk  yield,  pregnancy,  and  mastitis  (e.g.  injuries,  calving  diseases,  and 
lameness). The risks of forced exit were calculated from 16,145 lactations in the study 
farms and are detailed in Chapter 5. In the DP model they were slightly simplified as a 
constant monthly risk of 0.006, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, and 0.07 for the 1
st, 
2
nd, 3
rd, 4
th, 5
th, 6
th, 7
th, and 8
th lactation respectively. A mortality of 2% was added in  
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the after calving stage (first 3 days after calving).  
Effects  of  clinical  mastitis:  The  effects  of  CM  were  calculated  from  the  5  study 
farms. The milk losses associated with repeated cases of CM are detailed in Bar et al. 
(2007) and are summarized in Table 6.1 as the milk loss in the 1
st month, the 2
nd 
month, and the 3
rd month and later after CM. The mortality associated with CM is 
detailed Chapter 3. In the DP model it was simplified as 1% mortality in primiparous 
cows and 2% in multipara. A decision to treat the CM cow was associated with a cost 
of $50. This cost was an estimated average due to medications ($20), the decreased 
value of 5 days worth of discarded milk from an average production cow ($20), and 
extra labor ($10). The monthly risks of CM used in the DP model are summarized in 
Table 6.2. These were a slight simplification of the estimates detailed in Chapter4.  
 
Table 6.1. Milk loss (kg) from Generic clinical mastitis (CM) cases in the first 2 
months following CM, with milk loss constant after the second month. 
 
Parity  Days  1st CM  2nd CM  3rd CM 
1  0 30  116  137  137 
   31 60  67  76  76 
   >61  64  24  24 
         
2+  0 30  183  186  162 
   31 60  92  73  76 
   >61  73  43  52 
Source: Bar et al., 2007 
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Table  6.2.  Monthly  risks  (probability)  for  CM  occurrence  in  the  dynamic 
programming model, estimated from 16,145 lactations in 5 NY State dairy herds. 
Parity  Days1  1
st
 CM  2nd CM  3rd CM 
1  0 30  3%  5%  9% 
   31 60  1%  2%  8% 
   61 91  1%  2%  4% 
   >91  1%  2%  3% 
         
2  0 30  4%  9%  12% 
   31 60  2%  7%  10% 
   61 91  2%  4%  8% 
   >91  2%  4%  7% 
         
3  0 30  5%  10%  14% 
   31 60  3%  8%  12% 
   61 91  3%  5%  9% 
   >91  3%  5%  8% 
         
4+  0 30  6%  12%  16% 
   31 60  4%  10%  14% 
   61 91  4%  6%  10% 
   >91  4%  6%  9% 
1 Days after calving for the 1st CM case. Days after previous CM for repeated CM 
cases; Source: Chapter 4 
 
 
Methodology of estimation: 
Cost of forced policy: the average net returns per cow per year under the optimal 
replacement policy were compared to the average net returns per cow per year for a 
herd that used either an all CM treatment policy, a policy of replacing all cows if a 2
nd 
CM case occurred, or a policy of replacing all cows after their 3
rd CM case. The same 
estimation was also done under a 50% lower CM risk to get an estimate for these costs 
for farms with low CM incidence. To calculate the cost per CM case, the profit loss 
(compared  to  a  farm  with  no  CM)  was  then  divided  by  the  model simulated  CM 
incidence.  
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Cost benefit of fictitious CM vaccinations: the average net returns per cow per year 
under the basic scenario were compared to the average net returns per cow per year for 
a herd that used either a CM vaccination assumed to reduce the milk loss associated 
with Gram negative CM causing agents by 50% (Wilson et al., 2007), or a vaccination 
that additionally reduced the risk of CM by 50%. To calculate the cost per CM case, 
the profit loss was then divided by the model simulated CM incidence. 
Individual cow CM costs: estimated NPV for cows that are in their 3
rd lactation, and 
6  months  after  calving,  were  studied  to  gain  insight  into  the  effects  CM  (and 
pregnancy) have on these values. 
 
RESULTS 
Cost of forced policies  
The effects of policy changes on whole herd dynamics obtained by probabilistic 
Markov  chain  simulation  following  optimization  of  insemination  and  replacement 
decisions  is  presented  in  Table  6.3.  Treating  all  cows  with  CM  (i.e.  postpone 
replacement decision to the next month) had little effect on expected profitability and 
CM cost; the additional loss per cow per year was $2 compared to the optimal policy; 
the additional cost per CM case was $3. Culling all cows after their 2
nd CM case 
resulted in more pronounced effects: only 73% of the CM cases were recommended 
for treatment, model recommended culling increased by 5.2% and the cost incurred by 
following this policy was $27 per cow per year; the cost per CM case increased by 
more than 50%. If such policies were applied in farms with half the observed CM risk 
(20 cases per 100 cow years), then these additional CM costs per cow in the herd were 
halved.   
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Table 6.3. The effects  of policy  changes on whole herd dynamics obtained by 
probabilistic Markov chain simulation following an optimal replacement policy.   
 
  $ Net 
Return
1 
Milk 
yield
2 
Forced 
exit
3 
(percent) 
Model 
exit
4 
(percent) 
Total 
exit 
(percent)  
CM
5 
cases
6 
% of 
CM 
treated
7 
Cost 
per 
case
8 
Basic scenario 
Optimal 
policy  $355  11,424  18.3  17.3  35.6  39.7  91.9  $179 
                  Treat 
all CM 
cows 
$353  11,412  18.5  16.9  35.4  40.3  100  $182 
Cull all 
2
nd CM
 
cows 
$328  11,440  16.5  22.5  39.0  32.2  73.0  $304 
Cull all 
3
rd CM
 
cows 
$347  11,437  17.5  19.3  36.8  36.8  86.2  $215 
Low (50% of basic) CM risk scenario 
Optimal 
policy    $392  11,495  18.6  15.8  34.4  19.7  91.3  $175 
                  Treat 
all CM 
cows 
  $390  11,492  18.7  15.6  34.3  20.0  100  $178 
Cull all 
2
nd –CM
 
cows 
  $377  11,499  17.7  18.4  36.1  16.6  72.6  $292 
Cull all 
3
rd CM
 
cows 
$387  11,500  18.3  16.7  35.0  18.6  85.8  $210 
 
1 net returns in USD per cow per year 
2 kg milk per cow per year 
3 annual exit (%) from the herd from causes that were not model determined 
4 annual exit (%) from model recommended culling 
5 CM: clinical mastitis 
6 incidence of CM (cases per 100 cows per year) 
7 percent of treated CM cows per all CM cows 
8 average cost per CM case following an optimal replacement policy  
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Cost benefit of fictitious CM vaccinations  
The results of applying two fictitious CM vaccinations are presented in Table 6.4. 
Since the farms were using a J5 vaccine throughout the study the basic scenario is 
calculated by doubling the milk loss of CM caused by Gram negative bacteria. A 
vaccination that would result in reducing the milk loss caused by Gram negative CM 
by 50% was allowed to cost $14 per cow per year. A vaccination that would result in 
additional reduction of the risk of CM by 50% was allowed to cost $37 per cow per 
year.  
 
Table 6.4. The effects of two fictitious CM vaccinations on whole herd dynamics 
obtained by probabilistic Markov chain simulation following optimal replacement 
policy.   
 
  $ Net 
Return
1 
Milk 
yield
2 
Forced 
exit
3 
(percent) 
Model 
exit
4 
(percent) 
Total 
exit 
(percent)  
CM
5 
cases
6 
% of 
CM 
treated
7 
Cost 
per 
case
8 
No CM  $426  11,565  19.0  14.4  36.7  0.0  0.0  $0 
Basic 
scenario  $341  11,383  18.0  18.2  36.2  38.6  89.7  $220 
                 
Vaccination 
1
9  $355  11,424  18.3  17.3  35.6  39.7  91.9  $179 
Vaccination 
2
10  $392  11,495  18.6  15.8  34.4  19.7  91.3  $173 
 
1 net returns per cow per year 
2 kg milk per cow per year 
3 annual exit (%) from the herd from causes that were not model determined 
4 annual exit (%) from model recommended culling 
5 CM: clinical mastitis 
6 incidence of CM (cases per 100 cows per year) 
7 percent of treated CM cows per all CM cows 
8 average cost per CM case following an optimal replacement policy 
9 reducing the milk loss caused by Gram negative CM by 50% 
10 reducing the risk and the milk loss caused by Gram negative CM by 50% 
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Optimal individual cow CM treatment policy  
The DP model produces a table of more than 1.5 million expected NPV. Although 
it is not possible to report all of those values here, the values can be used to assist in 
individual cow CM treatment decisions. For instance, the NPV of some example cows 
(3
rd  lactation,  6  months  in  lactation),  differing  in  their  permanent  milk  yield, 
pregnancy and CM index, are presented in Table 6.5. The best policy recommended 
by the model is the action associated with the highest expected NPV. For example, a 
cow without CM, open, and with average milk production, would be recommended for 
insemination (and the cost of postponing insemination by one month would be $30); 
on  the  other  hand,  if  the  cow  is  low  producing,  the  model  recommended  that  the 
farmer keep her in the herd for at least one month, but not breed her. If such a low 
producing cow suffers her first CM episode, her NPV drops by $124 and she would be 
recommended for replacement; the cost of postponing her replacement by one month 
would be $3. A low producing cow with CM is recommended to be replaced even if 
she is pregnant; the cost of CM in that case is $187. An average or a high producing 
cow  is  recommended  for  insemination  even  if  she  contracts  CM.  Such  cows  are 
recommended to be treated even with higher treatment costs than we modeled. For 
example, for a pregnant high producing cow the break even point is $844. For an 
average producing cow this estimate is $301.  
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Table 6.5. Expected NPV (USD) of cows in their 3
rd lactation, 6 months after 
calving, obtained by the insemination and replacement optimization model.   
  Permanent production potential 
   5 kg
1  Average  +5 kg 
  Rep.
2  Keep  Ins.
3  Rep.  Keep  Ins.  Rep.  Keep  Ins. 
No CM, open  3749  3862  3849  3782  4118  4148  3816  4647  4699 
No CM, pregnant  3749  3928    3782  4374    3816  4990   
1
st CM, open  3741  3738  3717  3775  3888  3903  3809  4351  4395 
1
st CM, pregnant  3741  3737    3775  4076    3809  4653   
2
nd CM, open  3741  3744  3724  3775  3889  3914  3809  4364  4406 
2
nd CM, pregnant  3741  3743    3775  4048    3809  4659   
1 kg milk per day 
2 Rep.: Replace 
3 Ins.: Inseminate 
 
 
DISCUSSION 
The objective of this study was to demonstrate possible applications of a specially 
structured optimization and simulation model that included a detailed representation of 
repeated episodes of CM in assisting the CM decision making process. Two forced 
policies were modeled and compared to the optimal policy. The cost of treating all 
cows with CM (i.e. postpone replacement decision to the next month) was $2 per cow 
per year. The cost of replacing all CM cows after their 2
nd CM case was $27 per cow 
per year. The cost benefit of applying two fictitious vaccinations was calculated. A 
vaccination that would result in reducing the milk loss caused by Gram negative CM 
by 50% was allowed to cost $14 per cow per year. A vaccination that would result in 
additional reduction of the risk of CM by 50% was allowed to cost $37 per cow per  
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year.  Comparing  NPV  obtained  from  the  model  for  cows  with  similar  traits  but 
differing in CM state and pregnancy status can assist farmers in making quantitative 
economic CM treatment decisions. 
The values calculated here are relevant for the structure, parameters and prices 
utilized. As underlined by Seegers et al. (2003), any mastitis cost estimation in a herd 
is,  per  se,  of  low  external  validity.  Since  our  program  enables  editing  parameters 
before actual model building, the same model can be used to calculate disease costs 
under  other  dairy  parameters.  Despite  this,  the  CM  costs  derived  are  in  general 
agreement with other recent studies (Seegers et al., 2003; Østergaard et al., 2005). The 
model  developed  here  is  not  restricted  to  the  investigation  of  mastitis  economics. 
Similar diseases like lameness can be evaluated within the same model with necessary 
parameter changes. For the estimation of calving disease costs, an even simpler model 
would be adequate. 
Dynamic models such as the one presented here have the potential to become a 
useful decision aid tool in individual cow disease management, because the results are 
not only expressed as a recommended policy, but are also expressed as opportunity 
costs. By combining model results with additional factors (concerning the individual 
cow and the current herd situation), real time quantitative decisions are possible. To 
achieve well informed individual cow decisions, a more detailed representation of the 
milk yield of the cow would be useful. The current model is designed more for whole 
herd CM cost estimation and whole herd dynamics and therefore uses only limited 
milk yield levels.  
The  DP  approach  is  very  useful  in  searching  for  optimal  decisions;  stochastic 
simulation models as in Allore et al. (1998) and Østergaard et al. (2005) are better 
suited  to  simulate  optimal  decisions  under  uncertainty  since  they  do  not  use 
deterministic transition probabilities. Both approaches can be combined, i.e. after DP  
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optimization,  instead  of  simulating  herd  results  using  probabilistic  Markov  chain 
simulation, a Monte Carlo simulation can be used to better model the uncertainty of 
future events. 
The estimated cost of CM was very similar whether it was the first, second or third 
occurrence. This is because the milk losses associated with repeated CM are similar to 
the first case and the risk for the second CM is close to the risk for the third. The slight 
differences were not enough to change model recommendations. Therefore, generic 
CM  can  be  modeled  in  the  DP  state  space  as  a  cyclic  disease,  thus  enabling  the 
modeling of three different diseases simultaneously in the current model. 
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CHAPTER 7 
 
GENERAL DISCUSSION 
 
The objective of this thesis was to develop and present a framework for estimating 
the  economic  implication  of  clinical  mastitis  (CM)  under  various  scenarios. 
Production  losses  were  estimated  using  statistical  models  specially  suited  for 
representing these losses in the state space of a hierarchical Markov process model. A 
specially  structured  optimization  and  simulation  model  that  included  a  detailed 
representation of repeated episodes of CM was developed, and possible applications in 
the real world were demonstrated.  
CM can be caused by different pathogens, differing in their effects (Gröhn et al., 
2004; Gröhn et al., 2005). However, the current situation is that on most farms and for 
most  cases,  because  CM  milk  is  not  cultured,  the  farmer  has  to  weigh  treatment, 
culling and preventive measures options without knowledge about the CM causing 
agent. We were interested in the average economic burden of CM in these farms, and 
its relationships with other parameters, not in exploring exact biological pathways. To 
better understand the biology of CM, it would be essential to model pathogen specific 
CM, especially when addressing repeated cases. To be able to estimate repeated cases 
of pathogen specific CM, a larger number of observations is needed.  
We  purposely  chose  to  study  large,  high  producing  dairy  herds,  with  low 
incidences of contagious mastitis pathogens, as these are the farms that produce most 
of the milk in industrial countries (and this trend is likely to increase), and are also 
likely candidates for using such information and such quantitative tools for their own 
benefit. CM will apparently remain a major economic burden to the dairy industry if 
no  breakthrough  medical  development  is  achieved.  The  incidence  of  CM  in  our  
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sample  herds,  and  the  estimated  monetary  loss  associated  with  this  disease, 
demonstrate once more that despite the success of control programs against contagious 
mastitis pathogens (LeBlanc et al., 2006), CM remains a serious economical limiting 
disease in the dairy industry. 
Observational studies made in commercial herds inevitably suffer from various 
selection and misclassification biases; our study was no exception in this respect. A 
selection bias was present for instance because cows suffering from high milk losses 
after CM were culled as a result of low production, so that we could estimate only the 
losses of cows that were considered acceptable by the farmer. Therefore the CM losses 
calculated  in  commercial  farms  will  inevitably  be  biased  toward  the  null.  This  is 
especially so for the repeated CM cases. The exceptionally large dataset needed to 
estimate  repeated  CM  episodes’  effects  makes  the  wish  to  do  such  estimations  in 
research  herds  (with  a  forced  “no  cull”  policy)  a  prohibitively  costly  escapade.  A 
misclassification bias was for example present because some cases of CM were not 
identified; in this case we attributed the effect of undetected CM cases to the long term 
effect of the previous case. CM is a subjective definition: for example, in two out of 
five farms electrical conductivity and/or a drop in milk production were a trigger to 
check the cow again closely for CM signs, even if the cow had not been identified by 
the milkers as such; at the other end of the spectrum one farm fore stripped only cows 
that  the  milkers  suspected  to  have  CM  by  other  signs  (warm,  swollen  udders  or 
systemic signs). Addressing such interactions in our models was outside the objective 
of the thesis, but is needed if biological relationships are to be understood.  
The use of the semi parametric Cox model to estimate time to event (in our study 
either  death,  culling,  or  a  CM  case)  effects,  was  not  appropriate  for  obtaining 
parameter estimates for our economic model, as we needed the probability of events in 
a given time period (transition probabilities from each stage state action combination)  
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and in the Cox model the underlying baseline hazard is unspecified (Allison, 1995). 
Therefore we had to use other statistical models. This constraint caused convergence 
problems if an event had either zero or one probability in some combination of the 
covariates, and these combinations sometimes contained only a few cows. As we had a 
relatively large dataset, we could estimate the needed monthly probabilities without 
data manipulation.   
After the estimation of CM effects, the next step is to assign monetary value to the 
disease.  The  traditional  approach  that  adds  milk  loss,  increased  culling  costs,  and 
treatment costs to all CM cases might actually more than double count costs: not all 
cows will experience the full estimated milk loss associated with CM (because the 
farmer may decide to cull the cow at some point), the increased culling is to a large 
extent a voluntary decision of the farmer and not an unavoidable consequence, and not 
all cows with CM will even incur treatment costs (because the farmer may cull the 
cow  immediately  without  treatment).  We  have  therefore  to  find  a  framework  that 
incorporates the farmer (optimal) management of CM cows.  
The dynamic programming (DP) framework (Markov process) has the advantage 
of  finding  optimal  solution  for  sequential  decision  problems.  It  is  therefore  not 
surprising that soon  after the introduction of the DP algorithms, namely  the value 
iteration developed by Bellman (1957) and the policy iteration developed by Howard 
(1960) that this approach was adapted to solve the animal replacement problem (either 
alone or in connection with insemination and medical treatment). Already three years 
after the book by Howard (1960), an application to the dairy cow replacement problem 
was  published  by  Jenkins  and  Halter  (1963).  Their  model  only  included  the  trait 
“lactation number” (at 12 levels), and the permanent value of the study was only to 
illustrate that DP is a possible tool to be applied to the problem. A few years later, 
however, Giaever (1966) published a study which represents a turning point in the  
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application  of  the  method  to  the  animal  (dairy  cow)  replacement  problem.  He 
considered all three optimization techniques (value iteration, policy iteration and linear 
programming),  described  how  to  ensure  that  all  mathematical  conditions  were 
satisfied, and presented a model to describe the production and feed intake of a dairy 
cow.  
During  the  following  20  years,  several  dairy  cow  replacement  models  using 
Markov decision programming were published; Smith (1971) showed that the rather 
small model of Giaever (1966) with 106 states did not represent the upper limit. His 
state space included more than 15,000 states. Kristensen and Østergaard (1982) as 
well as van Arendonk (1984, 1985, 1986) and van Arendonk and Dijkhuizen (1985) 
studied the influence of prices and other conditions on the optimal replacement policy. 
The study by Ben Ari et al. (1983) deserves to be mentioned here. In that study 
the  main  difficulties  concerning  application  to  animal  production  models  were 
identified and clearly formulated: 
Uniformity because some traits may be difficult to define and measure. 
Variability because the traits vary at random among animals and over time. 
Reproductive cycle because the production of an animal is cyclic, it has to be 
decided in which cycle to replace as well as when to replace inside a cycle. 
Herd restraint, i.e. a restriction that applies to the herd as a whole and not to 
the individual animal. Examples of herd restraints are a production quota or a 
limited housing capacity. 
These  difficulties  were  studied  in  detail  and  partially  relaxed  in  the  thesis  of 
Kristensen  (1993b).  The  first  problem  is  actually  not  to  be  resolved  per  se  under 
current knowledge. We do not know the actual economic efficiency of an individual 
cow to turn feed into milk (not even her actual feed intake). Considering other aspects  
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of uniformity such as the ability to better define a trait as new information about the 
performance  of  a  cow  is  accumulated  (“learning”)  can  be  handled  through 
incorporating Bayesian updating techniques in the DP framework (Kristensen, 1993a). 
The  second  and  third  problems  are  solved  trough  the  DP  algorithm.  The  main 
disadvantage  of  this  approach,  namely  the  curse  of  dimensionality  (i.e.  the  model 
grows  to  a  prohibitory  size  as  soon  as  a  detailed  situation  is  modeled)  is  relaxed 
through  the  introduction  of  the  hierarchical  Markov  process  notation  (Kristensen, 
1988).  The  ability  of  taking  the  time  steps  out  of  the  matrix  enables  much  more 
detailed models to be solved, especially for infinite time horizon. The problem of a 
quota and capacity restrains are solved through defining a different objective function 
for the DP model i.e. either maximizing net return over milk production for a quota 
restrain or maximizing the net present value of a cow for capacity restrain (Kristensen, 
1989; Kristensen, 1991; Kristensen, 1993).  
Few studies addressed specifically the mastitis problem using DP. Yalcin and Stott 
(2000) and Stott et al. (2002) studied subclinical mastitis using a DP model with a 
stage length of a whole lactation. Their model enabled therefore replacement of cows 
only at the end of the lactation, and was not detailed enough to support individual cow 
decision support that is needed for describing the CM problem. The model of Houben 
et al. (1994) on the other hand, that used the hierarchic Markov process approach, is 
the most comprehensive animal replacement DP model reported to date. The state 
space of their model was almost 7 million, representing a large amount of realistic 
complexity; thus providing detailed individual cow clinical mastitis (as well as fertility 
and productivity) decision support. Several reasons encouraged us to construct a new 
model from scratch and not just update this model:   
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8.  New data on the effects of mastitis suggests a different model structure than in 
Houben’s model: The effect of mastitis on production (Gröhn et al., 2004) and on 
the  risk  of  culling  (Gröhn  et  al.,  2005)  was  shown  to  be  time  dependent.  The 
impact  on  milk  production  and  culling  was  shown  to be  high  close  to  disease 
occurrence and tapered off after about 2 months. This time dependency was not 
considered in Houben’s model. 
9.  In Houben’s model, the milk yield of a cow was represented as a combination of 
the milk yield in the current month and the milk yield of the last measurement in 
the previous lactation. Therefore not using the hierarchical Markov process to its 
full  benefit  (only  one  state  in  the  parent  process).  Since  farmers  evaluate  the 
performance of their cows as deviation from expectations or past performance, i.e. 
they have some prior knowledge about the cow (from her genetic potential and 
previous milk yield) and they observe the current milk yield in relation to this prior 
knowledge, we should present a model that fit this perception in a more natural 
way.  Furthermore,  such  a  representation  of  the  milk  yield  of  a  cow  is  also  in 
accordance with the statistical model that estimates the milk yield of a cow in 
relation to other cows in the herd.  
10.  We were interested in building a model that has a user friendly interface that 
enables parameter editing (prices, milk yield, and transition probabilities) before 
the optimization step. Furthermore we wanted the model to be transparent to the 
end user. 
The  application  program  interface  that  we  used,  the  Multi  Level  Hierarchic 
Markov  Process  software  (Kristensen,  2003),  proved  to  be  a  very  useful  tool  in 
addressing the above objectives. The curse of dimensionality problem, and the “black 
box” phenomenon of previous models (making possible mistakes nontransparent to 
the  programmer  and  the  end user),  could  be  effectively  relaxed.  The  size  of  the  
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matrices to be solved was reduced in two ways: first through the representation of age 
as stages in the multilevel hierarchical Markov process, and secondly through defining 
specific matrices for each stage state action combination. In our model the matrix size 
to be solved in each such combination was never more than 10 by 10. Thus, a very 
detailed model could be constructed and solved using a low end computer. Another 
major advantage of this software is the graphical representation of the model with easy 
exploration of transition probabilities and associated model parameters for each stage 
state action combination. The third objective was addressed through programming of a 
user interface that enables the display of default parameters, simple editing of them, 
and  the  ability  to  save  and  load  whole  sets  of  such  parameters.  The  forcing  of 
suboptimal  policies  as  done  in  chapter  6  was  also  relatively  straightforward  to 
program. Calculating optimal policies and simulation under the resulted optimal policy 
(to obtain whole herd estimates) requires only few mouse clicks.  
The values calculated in this thesis are relevant for the structure, parameters and 
prices utilized. As underlined by Seegers et al. (2003), any mastitis cost estimation in a 
herd is, per se, of low external validity. Since our program enables editing parameters 
before actual model building, the same model can be used to calculate CM costs under 
other  dairy  parameters.  Despite  this,  the  CM  costs  derived  here  are  in  general 
agreement with other studies using dynamic models (Houben et al., 1994; Seegers et 
al.,  2003;  Østergaard  et  al.,  2005).  Since  our  program  enables  editing  parameters 
before actual model building, the same model can be used to calculate disease costs 
under  other  dairy  parameters.  The  model  developed  here  is  not  restricted  to  the 
investigation of mastitis economics. Similar diseases like lameness can be evaluated 
within  the  same  model  with  necessary  parameter  changes.  For  the  estimation  of 
calving disease costs, an even simpler model would be adequate (because a calving 
disease  occurs  only  once  per  lactation  and  in  the  same  time  period  for  all  cows  
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affected). 
The  model  developed  in  this  thesis  is  not  suitable  for  evaluating  infectious 
diseases, because the Markov processes in the model are assumed to be independent. 
Therefore, the effect of keeping a cow that increases the risk of other cows having the 
disease  can  not  be  represented  using  such  a  model.  For  such  diseases,  simulation 
models are the appropriate framework. 
Dynamic models such as the one presented here have the potential to become a 
useful decision aid tool in individual cow disease management, because the results are 
not only expressed as a recommended policy, but are also expressed as opportunity 
costs. By combining model results with additional factors (concerning the individual 
cow and the current herd situation), real time quantitative decisions are possible. To 
achieve well informed individual cow decisions, a more detailed representation of the 
milk yield of the cow would be useful. The current model is designed more for whole 
herd CM cost estimation and whole herd dynamics and therefore uses only limited 
milk yield levels.  
The  DP  approach  is  very  useful  in  searching  for  optimal  decisions;  stochastic 
simulation models as in Allore et al. (1998) and Østergaard et al. (2005) are better 
suited  to  simulate  optimal  decisions  under  uncertainty  since  they  do  not  use 
deterministic transition probabilities. Both approaches can be combined, i.e. after DP 
optimization,  instead  of  simulating  herd  results  using  probabilistic  Markov  chain 
simulation, a Monte Carlo simulation can be used to better model the uncertainty of 
future events. 
The estimated cost of CM was very similar whether it was the first, second or third 
occurrence. This is because the milk losses associated with recurrent CM episodes are 
similar to those associated with the first case, and the risk of having a second CM is 
close to the risk of having a third. The slight differences were not enough to change  
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model recommendations. Therefore, generic CM can be modeled in the DP state space 
as a cyclic disease, thus enabling one to model three different diseases simultaneously 
in the current model. If pathogen specific CM is to be modeled and the effects of 
repeated cases are not substantially different from those of the first case, then this 
cyclic representation would enable one to model major groups of CM causing agents 
in parallel in the same  model with ease. Otherwise, our model will enable one to 
model such cases only one by one.   
 
SUMMARY 
In this thesis a framework for estimating production losses and monetary cost of 
generic  CM  was  developed  and  possible  applications  were  demonstrated.  Current 
information technology as online individual cow milk recording systems and detailed 
herd management programs enable individual farm estimations in a growing number 
of dairy farms. The developed dynamic optimization and simulation model with its 
user interface enables gaining insight into disease costs under farm specific conditions. 
Such a model can be used by dairy farmers, bovine practitioners, or extension experts 
to assist in disease management decisions and thus improve the profitability of the 
enterprise.  
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